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Abstract 
 
NEUROLOGIC MUSIC THERAPY TO IMPROVE SPEAKING VOICE IN INDIVIDUALS 
WITH PARKINSON’S DISEASE:  
 
 
Sarah Swann Solberg, MT-BC  
B.A., Gettysburg College 
M.M., Appalachian State University 
M.M.T., Appalachian State University 
 
 
Chairperson: Christine P. Leist, PhD, MT-BC 
 
 
Parkinson’s disease (PD) is a neurodegenerative disease that affects dopamine production 
in the motor areas of the brain leading to impairments in muscular control (Parkinson’s 
Foundation, 2018). Impairments in motor functioning can also impact respiratory control and 
voice production (America Speech-Language-Hearing Association, 2018). Neurologic Music 
Therapy (NMT) techniques have demonstrated the ability of music-based interventions to 
improve maximum phonation time, voice quality, articulatory control, and quality of life in 
people with PD (Azekawa, & LaGasse, 2018; Haneishi, 2001; Tamplin, 2008; Shih et al., 2012; 
Elefant, Baker, Lotan, Lagesen, & Skeie, 2012). This study sought to investigate how a music 
therapy protocol using NMT techniques impacts vocal functioning in people with PD. The 
effectiveness of specific Neurologic Music Therapy techniques targeting respiratory control and 
improving vocal functioning was explored. Six persons with idiopathic PD were enrolled in 
weekly one-hour music therapy sessions for 6 weeks. Data collection consisted of acoustic, 
perceptual, and self-report measures of voice were collected before and after a NMT intervention 
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protocol. The acoustic and self-report measures were found to have no statistically significant 
differences from pre to post-intervention testing. The results from the perceptual measures 
yielded statistically significant differences for characteristics of breathiness, pitch, loudness, and 
overall severity of voice functioning. The results indicate that Neurologic Music Therapy 
interventions may be beneficial in improving speaking voice in individuals with PD. Further 
research with larger sample sizes and control groups are necessary to determine if resulting 
statistically significant differences are generalizable to the PD population to yield clinically 
relevant changes.  
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Chapter One 
Introduction 
Parkinson’s disease (PD) is a neurodegenerative disease that affects the dopamine-
producing neurons in the substantia nigra portion of the basal ganglia in the midbrain. This 
degeneration of dopamine production leads to tremor, bradykinesia, rigidity, gait and balance 
problems, and difficulties with speech and swallowing (Parkinson’s Foundation, 2018). In 
addition to impairments in motor functioning, people with PD often experience behavioral 
symptoms such as apathy, depression, cognitive impairment, and difficulty with emotional 
regulation. Emotional regulation and controlled response of movements are the primary 
functions of the neurotransmitter dopamine (Parkinson’s Foundation, 2018). The Centers for 
Disease Control (2013) reported that PD is the second most common neurodegenerative disease, 
second only to Alzheimer’s disease, with its associated complications making it the 14th leading 
cause of death in the United States.   
According to the National Institute of Health (2010), nearly 500,000 people in the United 
States have PD with 50,000 new diagnoses a year. Across the world, there are more than 10 
million people living with PD. The Parkinson’s Foundation (2018) reported the disease is 1.5 
times more likely to affect men than women with incidence increasing with age. The American 
Speech-Language-Hearing Association (ASHA) (2018) reported that 70%-100% of people 
diagnosed with PD experience dysarthria, or speech changes and impairments affecting voice. 
Treatment for the disease is highly variable and often includes the use of dopamine promoting 
medications, such as Levadopa and Carbidoba. These medications can assist with a number of 
signs and symptoms including tremor, rigidity, and coordination of movement. Medications must 
be on a strict schedule to appropriately manage the reduction of debilitating signs and symptoms. 
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In addition to pharmacological treatments, there are two surgical options for people who have 
exhausted medical treatment or whose motor symptoms fluctuate and significantly affect their 
quality of daily living. The most common surgical option, deep brain stimulation, is only 
effective in treating symptoms that have positively responded to previous medical treatments. 
The second surgical option involves inserting a tube into the intestine that will automatically 
administer medication to the patient through an external pump. In addition to these treatments, it 
is recommended by the Parkinson’s Foundation recommends people with PD begin regular 
exercise for 2.5 hours per week focusing on flexibility, cardiovascular activities, and strength 
training. Symptoms affecting speech, voice, and swallowing require interventions by speech-
language pathologists, or other related rehabilitation professionals, such as music therapists 
(Parkinson’s Foundation, 2018).  
Laryngeal Phonation 
Laryngeal structure and musculature. The laryngeal complex is comprised of several 
muscles, cartilages, and one bone. The single hyoid bone is located between the mandible and 
the thyroid cartilage. There are two unpaired cartilages, the thyroid and the cricoid cartilage. The 
thyroid cartilage is oriented superior to the cricoid cartilage. In addition to these cartilages, there 
is one pair of cartilages called the arytenoid cartilage. When phonation is initiated, the cartilages’ 
positions are adjusted using a combination of muscle movements. Muscles are responsible for 
bringing the vocal folds together and closing the glottis, which is the space between the vocal 
folds, are the thyroarytenoid muscles, the lateral cricoarytenoid muscle, and the inter-arytenoid 
muscles (transverse and oblique). The names of the muscles indicate the muscular origin and 
insertion attachments on the cartilages. The only muscle responsible for adduction of the vocal 
folds is the posterior cricoarytenoid muscle. The muscles responsible for lengthening and 
 3 
shortening the vocal folds are the thyrovocalis muscle, also known as the deep fibers of the 
thyroarytenoid muscle, and the cricothyroid muscle (Sapienza & Ruddy, 2018, pp. 21-58). 
Aerodynamic Principles of Phonation. Laryngeal aerodynamics help to explain the 
relationship between air flow and pressure during respiration and phonation. The aerodynamic 
principle of phonation states that when resistance is increased in the laryngeal framework the 
flow of air is restricted forcing the need for additional pressure to produce phonation (Sapienza 
& Ruddy, p. 88, 2018). Age and voice disorders can have a marked effect on the aerodynamic 
functioning of the laryngeal framework. As an individual ages the cartilage in the larynx begins 
to ossify. This ossification process can lead to changes in how the larynx functions 
biomechanically (Sapienza & Ruddy, p. 96, 2018). Different measures help determine laryngeal 
aerodynamic changes and the presence of voice disorders. Maximum phonation time (MPT) and 
s/z ratio are both useful tools in examining a patients aerodynamic functioning. Maximum 
phonation time, or the greatest amount of time a person can sustain a vowel after maximum 
inhalation, indicates the persons vital capacity, or how much air can be exhaled after inspiration. 
The s/z ratio is measured by dividing the duration of the voiceless fricative /s/ by the voiced 
fricative /z/. The higher the ratio score the more likely the presence of a voice disorder (Sapienza 
& Ruddy, p. 97, 2018). 
Acoustic Variables of Phonation. The acoustic variables in this study include: 
fundamental frequency (Fo), jitter, shimmer, maximum phonation time, and s/z ratio. The 
fundamental frequency (Fo) refers to the speed of the vocal fold vibration which relates to the 
pitch of the voice and is measured in Hertz (Sapienza & Ruddy, p. 445, 2018). The variability of 
fundamental frequency indicates the amount of prosodic change to the voice during typical 
speaking. Lowered variability of the fundamental frequency may be an indication of a voice 
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disorder and is present in changes to the voice from Parkinson’s disease. Decreased range of the 
fundamental frequency can also be indicative of a reduction in the useable vocal range during 
speech (Bowen, Hands, Pradhan, & Stepp, 2013).  
Increased jitter, as an indicator of cycle-to-cycle variation of fundamental frequency, 
indicates the presence of vocal pathology (Sapienza & Ruddy, 2018, p. 447). Shimmer is the 
cycle-to-cycle variation of voice waveform amplitude. When increased, it also indicates the 
presence of vocal pathology (Sapienza & Ruddy, p. 454, 2018). A study which compared 
tremulous voice common in PD to healthy controls found that people with PD presented with 
irregular sound waveforms, as well as, higher scores and greater variability in percent shimmer 
and jitter when compared to healthy controls. The authors also found that people with PD had 
higher instances of long-term tremor frequency modulation (Fftr) (MacCallum, Zhang, & Jiang, 
2010). The findings of this study indicate that people with PD have statistically significant 
instances of tremulous voice when compared to healthy adults.  
Increased maximum phonation time from pre- to post-test indicates improved 
functionality of the respiratory system. A person’s maximum phonation time indicates their 
individual lung capacity and ability to control their laryngeal framework. Abnormality and 
impairment of the laryngeal framework and valving may lead to decreases in maximum 
phonation time (Sapienza & Ruddy, 2018, p. 97). Motta, Cesari, Paternoster, Motta, and Orefice 
(2018) studied the correlation between aerodynamic measures and vocal disability in people with 
Parkinson’s disease. There were 15 male participants in the study diagnosed with Parkinson’s 
disease. Aerodynamic measures of maximum phonation time, subglottal pressure, phonatory 
power, and phonatory resistance were taken using a computerized speech system. The findings 
indicated that the patients all had statistically significant reductions in their maximum phonation 
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time as compared to healthy controls. The authors noted that this reduction in MPT is indicative 
of functional changes within the laryngeal mechanism.  
The s/z ratio compares expiratory control during an unvoiced consonant to sustained 
phonation on a voiced consonant. An increased score on the s/z ratio can indicate the presence of 
vocal pathology because of the inefficiency of the vocal fold adduction (Eckel & Boone, 1981). 
Decreased s/z ratio from pre- to post-test indicates improved adduction of the vocal folds during 
phonation.   
Voice 
 Voice is created through the combination of air through the larynx which vibrates the 
vocal folds. When the breath is expired, the diaphragm contracts with assistance from the 
abdominal muscles and expels the air through the laryngeal glottis, the space between the vocal 
folds, and out of the mouth and nose. During phonation, the vocal cords are brought together and 
create an undulating vibration resulting in phonation. The act of phonation requires great 
coordination between the laryngeal muscles, cartilages, and hyoid bone, as well as, organizing 
the dynamic movement of the diaphragm and lungs (Sapienza & Ruddy, 2018, pp. 1-20).  When 
used for communication, the voice includes variation in perceptions of pitch, perception of 
loudness, and perception of inflection that can be indicative of patient’s identified gender and 
age. 
Speech 
The National Institute on Deafness and Other Communication Disorders (NIDCD; 2017) 
stated that speech is personal expression through the coordination of the voice, speech 
articulators, and breath into discernible patterns which indicate specific messages. The 
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articulators of speech are the lips, teeth, tongue, jaw, and velum. The head, neck, chest, and 
abdomen are all involved in the production of speech.  
Singing 
Garcia-López and Gavilàn Bouzas (2009) investigated the physiological changes that 
occur in the laryngeal complex and speech mechanisms when singing. Both singing and speaking 
voice requires breath, resonation, posture, emission, and articulation. Singing, however, requires 
greater use of the abdominal muscles to maintain a specific musical note and phonatory intensity. 
Furthermore, complete glottic closure must be maintained for longer periods of time when 
singing and is necessary to progress through the vocal range. Resonance is required for both 
singing and speaking and is partially responsible for our ability to differentiate between two 
individuals’ voices. When singing, resonation helps the singer amplify their tone with minimal 
muscular effort.  These changes in tone act to express different emotion when singing, and also 
to project tones to the listeners.  Therefore, the muscular demands needed when singing are 
greater than those needed for speech.  
Music Therapy 
The American Music Therapy Association (AMTA, 2018) defines music therapy as the 
use of music interventions based on clinical and scientific evidence to address individual goals 
and built on a therapeutic relationship between client and music therapist. Music therapy must be 
administered by a board-certified music therapist who has completed a bachelor’s degree of 
higher education from a music therapy program approved by the American Music Therapy 
Association. Music therapy techniques can be beneficial for a wide range of populations 
including children, adolescents, adults, and older adults. Evidence has shown that music therapy 
strategies can address psychosocial well-being, physical rehabilitation, and communication 
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problems (AMTA, 2018). It is important to differentiate music therapy from supportive 
musicians with specific populations. For example, a musician who performs music at an assisted 
living facility would not be considered a music therapist if they have not received the required 
education and completed the board certification process. The use of music in a therapeutic 
setting requires significant knowledge of musical structures as well as training in anatomy and 
physiology and psychology. Music therapy offers a unique opportunity for vocal rehabilitation as 
an activity to improve quality of life for people with PD. A study looking at the effectiveness of 
singing-based interventions on communication and voice in people with PD (2019) stated:   
Singing demands increased respiratory support, louder and more sustained phonation, and 
greater pitch variation and articulation than talking, thus theoretically targeting many 
elements of impaired speech in PD. (Tamplin, Morris, Marigliani, Baker, and Vogel, p. 
454, 2019) 
The multi-faceted nature of music makes it a unique treatment strategy to treat speech 
impairments, however, these same aspects of music therapy make it conducive to therapeutic 
change for voice disorders, as well. Therefore, given the known decreased laryngeal functioning 
and reduction in vocal fold adduction for people with PD and the known positive effects of these 
variables using specific music therapy intervention, there is a need for research investigating 
music therapy interventions for individuals with PD. 
Neurologic Music Therapy (NMT) 
According to the Handbook of Neurologic Music Therapy, Neurologic Music Therapy 
(NMT) is the use of standardized music therapy techniques that can address functional physical, 
speech, and cognitive abilities. There are 20 techniques included in the NMT handbook, all with 
extensive research backing their effectiveness. The techniques included in NMT are focused on 
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neuroanatomy and development and have substantial scientific evidence supporting their use 
with a multitude of populations and ages. NMT is particularly effective as treatment for 
neurological disorders affecting movement and functioning including voice disorders and gait 
from PD (Thaut & Hoemberg, 2015).  
Voice, Music Therapy, and PD 
 Music therapy through singing and respiratory exercises can be a beneficial non-
pharmacological intervention to improve voice in people diagnosed with Parkinson’s disease. A 
literature review (García-Casares, Martín-Colom, & García-Arnés, 2018) studying the 
therapeutic effects of music therapy in Parkinson’s disease found that interventions with non-
motor symptoms, such as, voice quality, respiration, and quality of life, showed seven articles 
found statistically significant improvement in symptoms after interventions lasting longer than 
one month. The authors of the review stated that MT may be beneficial in improving vocal 
functioning and respiratory strength.  
 Stegemöller et al. (2017) conducted a descriptive study by interview of the experiences of 
people diagnosed with Parkinson’s disease who had undergone group singing music therapy. The 
questions in the interviews involved categories of program enrollment, engagement, 
participation, and evaluation. The findings indicated that the participants stressed the importance 
of alternative treatments to improve quality of life through voice and lifestyle, among others. The 
participants in the reviewed study also found that the group aspect of the singing intervention 
provided opportunities for positive social interaction. The participants also expressed feeling that 
the singing interventions were most beneficial in helping them train and improve their voices and 
respiration. Overall, the participants reported that the music therapy interventions gave them the 
opportunity to improve their vocal functioning and quality of life.   
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 Stegemöller, Radig, Hibbing, Wingate, and Sapienza (2017) studied the effectiveness of a 
singing intervention on vocal outcome measures and quality of life in individuals diagnosed with 
Parkinson’s disease in either a low dosage or high dosage intervention. The authors hypothesized 
that vocal, respiratory, and quality of life measures would improve across dosages. There were 
27 total participants in the study who were selected to participate in either the low dosage or the 
high dosage treatment conditions. Low dosage participants received 60-minute group sessions 
once per week, and high dosage participants participated in 60 minutes group sessions twice per 
week. Measures were taken pre and post-intervention and included measurements of phonation 
duration, lowest and highest fundamental frequency, vocal intensity, respiratory pressure, and 
quality of life. The intervention was administered by board-certified music therapists and 
included exercises designed to address breath support, vocal intensity, and range. In addition to 
the weekly sessions, participants were asked to perform at-home exercises and results of this 
practice were self-reported by the participants. The results of the study indicated that there was 
no statistical difference between the high and low dosage singing interventions. Maximum 
phonation time and the Voice-Related Quality of Life measure both showed statistically 
significant improvements from pre to post-intervention testing. Respiratory measures also 
showed a statistically significant improvement. The results of this study suggest that singing 
interventions led by board-certified music therapists may help to improve focal and respiratory 
functioning in people diagnosed with Parkinson’s disease. 
Voice-Related Quality of Life 
 Takahashi, Kamide, Suzuki, and Fukuda (2016) studied the importance of 
communication and relationships in the quality of life of people diagnosed with Parkinson’s 
disease. The researchers utilized a not previously studied quality of life measure aimed at 
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measuring all quality of life domains for people with Parkinson’s disease. The effectiveness of 
this measure was compared to other disease specific questionnaires measuring motor 
functioning, activities of daily living, and quality of life. There were fifteen participants in the 
study diagnosed with idiopathic Parkinson’s disease. The study found that a lack of social 
relationships significantly impacts quality of life in individuals with Parkinson’s disease. An 
ability to communicate was also found to be a significant factor in the forming of important 
social relationships. The results of their study found that this new questionnaire was strongly 
correlated to domains associated with social relationships. The authors noted, however, that this 
study was conducted in Japan indicating that cultural differences may affect the importance of 
different domains.  
 McAuliffe, Baylor, and Yorkston (2017) investigated the relationship between the 
Communication Participation Item Bank (CPIB) and other health-related quality of life 
measures. There were 378 participants in the studied diagnosed with Parkinson’s disease from 
the US and New Zealand.  The CPIB is a self-report measure designed to rate how much a voice 
disorder affects daily communication. The results of this study found that a higher rating of 
perceived speech impairment indicated reduced communication. The study also indicated that a 
person’s perception of their voice impairment may be a better indicator of reduced 
communication than other measurements. The study concludes that the CPIB may be effective in 
determining the multi-faceted complexity of communication difficulties in individuals with 
Parkinson’s disease. It further posited that a person’s perceived difficulties with communication 
may negatively affect their quality of life.  
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Confounding Factors 
 There are several biases which may have impacted the design of this study. All 
participants were obtained from a convenience sample, which may have increased the inclusive 
sampling bias of the participants. The small demographic range makes the results of the data not 
generalizable to the general population. Response bias of the participants on the self-report 
measures may have also skewed the impact of the participant’s vocal impairment on their daily 
lives. A final confounding factor is the possible measurement error due to random responses to 
medication resulting in dyskinesia during final measurements.   
Research Question 
How will a music therapy protocol using NMT techniques improve vocal functioning in 
people with PD? 
Statement of Purpose 
The purpose of this study was to explore the impact of how a music therapy protocol 
using NMT techniques impacts speaking voice and voice-related quality of life in individuals 
with PD based on acoustic, perceptual, and self-report measures before and after treatment. 
Singing interventions (Azekawa & LaGasse, 2018; Haneishi, 2001; Tamplin, 2008; Shih et al., 
2012; Elefant et al., 2012) have been shown to improve functionality of the vocal mechanism for 
people with PD; therefore, our overarching hypothesis is that music therapy interventions 
focusing on phonation will have a positive effect on the client’s communication in daily life. 
Improved communication in people with PD has been shown to improve daily quality of life and 
increase effective communication of wants and needs (Takahashi et al., 2016; McAuliffe et al., 
2017) 
 This study will address the following specific aims: 
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Specific Aim 1: To examine the effects of NMT techniques on voice production following an 6-
week treatment period as measured by acoustic variables. 
It is hypothesized that participants will have 
a. decreased frequency of tremor at F0  
b. decreased percent jitter during sustained vowel phonation and standardized reading 
passage. 
c. decreased percent shimmer during sustained vowel phonation and standardized 
reading passage. 
d. decreased F0 variability during a sustained vowel /a/ phonation.  
e. increased maximum phonation time (MPT) (seconds) during sustained vowel 
phonation of /a/. 
f. increased range of fundamental frequency (PFT) in semi-tones during standardized 
reading passage.  
g. increased average intensity (dB) during sustained vowel phonation and standardized 
reading passage.  
h. change in average F0 during a standardized reading passage 
a. men will experience a decrease in average F0 
i. maintain an s/z ratio less than 1:4 across two trials. 
Specific Aim 2: To examine the effect of NMT voice protocol on perception of voice quality 
following 6-week intervention period as measured by CAPE-V.  
It is hypothesized that participants will have a decreased score on the CAPE-V.  
Specific Aim 3: To examine the effect of NMT voice protocol on voice-related quality of life as 
measured by VR-QOL and VHI.  
 13 
It is hypothesized that participants will have a decreased score on the VR-QOL and VHI.  
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Chapter Two 
Literature Review 
This chapter is a review of the literature of traditional speech-language pathology 
methods used to address voice disorders in people with PD. This review also includes a 
discussion of music therapy strategies used with this population.   
Aerodynamics and Phonation in Parkinson’s Disease 
A study of the aerodynamic changes in people with PD by Ikui et al. (2014) investigated 
the differences in vocal frequency changes, expiratory pressure during phonation, and vocal 
intensity during phonation between people diagnosed with PD and health age- and gender-
matched controls. All 30 participants in the experimental group had been diagnosed with PD and 
visited the outpatient clinic at the Oklahoma City University Hospital. A special instrument, the 
Vocal Function Analyzer, was developed to take acoustic and respiratory measurements 
simultaneously and noninvasively. In relation to voice pitch, the results showed that people with 
PD had no significant difference in pitch range compared to their healthy controls, however, 
highest pitch range was notably lower in people with PD across genders. The lowest pitch was 
significantly higher in the experimental group versus the control group. There were no notable 
differences between the comparison and experimental groups in reference to expiratory pressure 
or vocal intensity during phonation. The authors hypothesized that this lack of statistical 
difference in expiratory pressure and vocal intensity could be explained by the reduced oral 
cavity opening common in people with PD. The authors also posited that continuing to 
encourage the use of effortful speech during conversation might assist in increased speech 
intelligibility and vocal intensity in patients with PD. PD affects muscle functioning, including 
vocal rehabilitation techniques have been developed to address decreased laryngeal muscle 
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functioning in people with PD. These techniques and have been found to be particularly 
beneficial in maintaining appropriate vocal functioning in people with Parkinson’s disease as 
they age. 
Fang, Hwang, and Chen (2014) measured differences in voice quality, maximum sound 
prolongation, and s/z ratio between people diagnosed with PD and a healthy control. The study 
included 16 men with an average age of 68 diagnosed with PD varying from stages 2 to 4 on the 
Hoehn and Yahr scale. There was also a healthy control group matched for age and gender. An 
audio recording was taken of maximum phonation of the phonemes /a/, /f/, /s/, and /s/, and 
monosyllable sounds of /pa/, /ta/, and /ka/, and trisyllables of /pataka/ as fast as possible in a 
single breath for three trials. Measurements of average fundamental frequency (Fo), jitter, 
shimmer, and noise-to-harmonics ratio (NHR) were taken using a standardized computer 
program. The s/z ratio was measured by dividing the duration of the voiceless fricative /s/ by the 
voiced fricative /z/. The results indicated that the healthy control had a greater duration of 
sustained vowel phonation that the individuals diagnosed with PD across phonemes and fricative 
trials. The s/z ratio findings showed that there were no statistically significant differences 
between groups. Furthermore, voice quality in Fo and NHR were found to have no significant 
differences. The authors stated that their findings in regards to jitter, shimmer, and s/z ratiowere 
contrary to previous studies and suggested that the small sample size could have attributed to the 
lack of statistically significant findings. They suggest further research to determine further 
differences in aerodynamic changes for people diagnosed with PD and healthy controls.  
Speech-Language Pathology Interventions 
Matheron, Stathopoulos, Huber and Sussman (2017) found healthy older adults had better 
laryngeal control when compared to adults with PD when increasing sound pressure level of 
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speech. The study measured 20 healthy older adults with an age range of 60 to 81 years and even 
gender distribution, and 42 adults with PD with an age range of 37 to 86 years and 
predominantly male. Participants were required to be native speakers of English with no history 
of neurological disease besides PD, no respiratory disease, functional hearing in at least one ear, 
and no history of smoking in the past 5 years. Additionally, for the individuals with PD, a 
diagnosis by a speech-language pathologist or a self-perception of hypophonia was needed. 
Subglottal pressure, intraoral air pressure, and laryngeal airflow were measured for speech-in-
quiet and speech-in-noise during a standardized speech task. The results showed no significant 
differences between the groups for mean sound pressure level, maximum flow declination rate, 
and minimum flow; however, statistically significant differences were found between groups for 
estimated subglottal pressure, peak-to-peak flow, and open quotient, or the ratio of how long the 
vocal cords are open during a cycle to the time of the entire cycle, in the speech-in quiet 
condition. The participants with PD showed significantly decreased open quotient measures from 
speech-in-quiet to speech-in-noise conditions. Significant differences were found in all measures 
except the minimum flow measure in the speech-in-noise condition. The results indicated that 
when speaking at a normal, comfortable level there were no significant differences in the rate of 
vocal fold closure to midline and airflow at maximal vocal fold closure between the control and 
the PD group; however, the open quotient differences indicated that healthy older adults show 
more ability to control muscles associated with laryngeal adduction. This suggested that 
individuals with PD spent more time on average with vocal folds open than their healthy controls 
resulting in vocal fatigue and decreased vocal intensity during conversation. Furthermore, 
estimated subglottal pressure may be affected by difficulties with adductor muscle control in the 
laryngeal mechanism in people with PD. These findings indicated that healthy older adults may 
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have more laryngeal efficiency in regard to vocal fold closure and therefore do not tire as easily 
when talking. Based on their findings, the researchers suggested vocal rehabilitation techniques 
that promote increases in vocal intensity while speaking. Voice strengthening therapy provided 
by a speech-language pathologist is especially effective in the treatment of vocal disorders for 
people with PD. 
Smith, Ramig, Dromey, Perez, and Samandari (1995) investigated the effect of intensive 
voice treatment for people with PD based on rigid and flexible laryngostroboscopic 
measurements. Laryngostoboscopy is the use of a scope to visualize vocal cord functioning. The 
scope is equipped with a stroboscopic light output that that allows the movement of the vocal 
cords to be visualized with the naked eye. The authors used two treatment strategies to address 
phonation in persons with PD. The two treatment protocols were respiratory interventions and 
voice and respiratory therapy. Laryngostroboscopic measurements were taken pre- and post-
intervention. The authors hypothesized that voice and respiration therapy would have a greater 
impact on laryngeal adduction and improved sound-pressure level based on increased vocal 
effort when compared to respiratory interventions alone. Twenty-two patients diagnosed with PD 
participated in the study with a representative sampling based on gender, age, and stage of the 
disease. Initial laryngostroboscopic measurements and preliminary voice-recording sessions 
were taken one month prior to the beginning of therapy. The initial findings determined 
inadequate glottal functioning and hyperfunctioning of the larynx. Measurements were also taken 
to determine the amount of vocal cord bowing and other vocal abnormalities apparent in each 
participant. The subjects participated in 16 treatment sessions across a 4-week period. 
Laryngostroboscopic measurements and voice-recording sessions were taken post-treatment and 
compared to the results of the pre-treatment measurements. The findings indicated participants 
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receiving vocal and respiratory interventions demonstrated greater improvements in laryngeal 
adduction and glottal closure than those who received respiratory therapy alone. These 
progressions in vocal fold functioning led to increased vocal intensity. The authors concluded 
that the evidence supported the hypothesis that the combination of voice and respiratory 
interventions can help to improve vocal fold adduction and be beneficial in the treatment of 
voice changes in people with PD. 
De Angelis et al. (1997) examined the effect of a group vocal rehabilitation program on 
patients with PD. There were 20 participants in the study, all of whom had a stable 
pharmacological regimen. The participants attended three 45-minute sessions a week for one 
month. Measurements were taken pre- and post-intervention to determine peak phonation time 
based on sustained vowels and the phonemes /s/ and /z/, and rate of air flow. Participants also 
completed a self-evaluation of swallowing and level of oral communication before and after 
treatment. The interventions included asking the participants to push their arms from an upright 
to a lowered position while phonating. The authors reported that this pushing exercise had a 
marked effect on the patient’s loudness and resonation. Over-articulation of phonemes was also 
used to improve glottic closure. After treatment, the post-intervention measurements indicated 
that the intensive vocal rehabilitation protocol produced increased vocal intensity, more effective 
vocal cord closure and subglottic pressure and efficiency, wider pitch range, and secondarily, 
improved swallowing function. A month following the treatment, the researchers repeated their 
measurements and found that the improvements were maintained. Additionally, alternative 
treatments, such as voice therapy and therapeutic singing, have shown to help improve 
articulation and intelligibility, vocal intensity, and quality of life in people living with PD.  
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Simberg, Rae, Kallvik, Salo, and Martikainen (2012) studied the effects of a 15-day 
intensive speech therapy intervention on vocal functioning of people diagnosed with PD. The 
study included six participants, four men and two women, with an average age of 64 years, who 
had no signs of dementia and no previous speech therapy. The study was conducted at a 
rehabilitation center in which the participants resided for the duration of treatment. The treatment 
included 10 individual 30-minutes speech therapy sessions, nine 60-minute sessions in a group 
setting, and two one-hour evening sessions as a group with a focus on speech and voice 
exercises. The treatment was subdivided into two parts of 10 and 5 days respectively with a 3-
month interlude in between treatments during which time the participants were given at home 
exercises. Acoustic measurements of fundamental frequency, vocal range, sound pressure levels, 
and quality of speech (breathy, strain, roughness, etc.) were taken using recordings of range of 
speech through sentence reading, spontaneous speech, and glissandi from highest to lowest pitch 
in both a weak and loud voice. These recordings were taken the second day of the first part of 
treatment, the last day of the first part of treatment, and the beginning of the second part of 
treatment. In addition to these recordings, participants also completed the Voice Activity and 
Participation Profile four weeks prior to beginning treatment, 6 months after treatment, and 1 
year after treatment.  
Simberg et al. (2012) study showed that the average fundamental frequency increased 
from 130.27 Hz at the start of treatment (SD = 40.15) to 150.64 Hz (SD = 47.54) 3 months past 
beginning of treatment. Sound pressure levels were shown to increase from the beginning to the 
end of the first part of treatment but returned to baseline following the 3-month break. Vocal 
range increased for all participants. The self-reported questionnaires indicated the participants 
perceived their symptoms to be less severe after receiving treatment. Responses indicated an 
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improvement in quality of life through reduction of symptoms and increase in peer support 
through the group treatment. In addition to these findings, improvements in voice grade, 
roughness and instability maintained three months after the first part of treatment. The authors 
concluded that intensive vocal rehabilitation can be effective in improving vocal functioning in 
people diagnosed with PD; however, because of the small sample size, they suggest caution in 
generalizing the results. Additionally, negative carryover effects were seen through the 
deterioration of abilities between the two parts of the rehabilitation treatment.  
Lee Silverman Voice Treatment (LSVT-Loud) 
Dromey, Ramig, and Johnson (1995), studied the use of the Lee Silverman Voice 
Treatment on the phonatory and articulatory changes common among people diagnosed with PD. 
The study followed the progression of one patient with PD while he underwent the intensive Lee 
Silverman Treatment. According to the LSVT Global website, the Lee Silverman Voice 
Treatment is a comprehensive vocal rehabilitation strategy focused on addressing vocal intensity, 
articulation, and quality for people with PD (LSVT Global, 2018). The patient attended 16 
sessions over a 4-week period. Pre- and post-treatment measurements were taken to determine 
phonatory and articulatory behavior. Post-treatment measures were conducted a week after 
treatment ended, and 6 and 12 months after treatment to ascertain carryover effects after 
significant time without treatment. The data included measures of sound pressure level for 
sustained phonation, conversational speech through reading and a monologue, and syllable 
repetition. Articulatory acoustics were determined using the recitation of a series of 70 
monosyllabic words with a direction to read clearly. The data showed that after treatment vocal 
intensity increased during sustained vowels, reading, and monologue recitation. These changes 
were still apparent at the 6-month and 12-month time points. Sub-glottal air pressure also 
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increased from pre- to post-testing and remained at later testing. Vocal fold adduction also 
improved after treatment and continued at further measures. The authors hypothesized vocal and 
laryngeal musculature became stronger because of the intensive vocal treatment. The data 
indicated that intensive vocal interventions had a significant effect on vocal intensity and 
articulation apparent in people with PD. 
Sackley et al. (2018) compared the Lee Silverman Voice Technique (LSVT Loud) to 
traditional speech and language therapies and no treatment in people diagnosed with PD. The 
study included 27 participants randomly assigned to receive LSVT Loud, 27 to speech therapy, 
and 29 to the no treatment control group. The participants had an average age of 67 years and 
were mostly male across conditions. All participants had idiopathic PD with no dementia, self- or 
caregiver reports of speech problems, and no previous laryngeal pathology. The treatments were 
provided either at community-based healthcare establishments or outpatient neurology units in 
the United Kingdom. Participants in the LSVT Loud treatment condition received four 50–60 
minutes sessions per week for 4 weeks by a registered speech-language pathology with a 
certification in LSVT. In addition to these treatments, participants received 5–10 minutes of 
homework on treatment days and up to 30 minutes of homework on nontreatment days. The 
treatments consisted of maximum effort nonspeech and speech drills. The participants in the 
speech-language therapy (SLT) condition received one 45-minute session per week for 6–8 
weeks with varying content based on patient need. This content could include exercises in 
respiration, phonation, articulation, behavioral strategies to reduce prosodic abnormality, and use 
of augmentative and alternative communication strategies. The no treatment control group 
continued to receive their usual PD treatment and were prohibited from receiving speech therapy 
services until at least 6-months poststudy unless deemed medically necessary. Patients completed 
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the Voice Handicap Index (VHI), and the voice-related quality of life (V-RQOL) questionnaire 
among others and further perceptual measurements of vocal loudness, comprehension 
assessments, and assessment of intelligibility of dysarthric speech were recorded. The Vocal 
Handicap Index results showed a reduction in total scores for the LSVT Loud and speech therapy 
conditions from baseline to three months post treatment. The largest difference was seen in the 
LSVT results with greater reduction of scores for participants receiving LSVT than those 
receiving speech therapy. The findings indicated that both LSVT Loud and traditional speech 
therapy treatment options may be effective in improving voice for people with PD; however, 
there was high attrition for individuals receiving LSVT treatment, which suggested the intensity 
of the treatment may increase participant drop out.  
Singing as a Therapeutic Intervention for Voice Disorders 
Non-Music Therapy Studies. Shih, et al., (2012) compared the use of group singing as a 
treatment strategy to address communication impairments to the Lee Silverman Voice Treatment 
in people with PD. There were 13 subjects who participated in the duration of the study for all 
assessment measurements. The authors hypothesized that the measurements taken pre-, post-, 
and after an additional 12 weeks post-treatment would be similar to the findings associated with 
the LSVT treatment. In this study, the subjects participated in 90-minute singing intervention one 
time weekly for 12 weeks. The findings, however, did not support the hypotheses. Measurements 
of vocal intensity, articulation, fundamental frequency, and pitch range showed no significant 
improvements from pre- to post-test measurements. The authors stated that these findings could 
be caused by the less intensive training of this study as compared to LSVT. Further research 
which includes comparison groups, a larger sample size, and increased frequency of treatment to 
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further investigate the use of group singing as a valid treatment option for communication 
impairments in people with PD is needed. 
Harris, Leenders, and de Jong (2016) studied the effectiveness of singing familiar 
melodies on vocal behavior during vocal improvisation for people diagnosed with PD. The 
rationale for the study was based on the findings of music therapy for Rhythmic Auditory 
Stimulation for gait training described in the Handbook of Neurologic Music Therapy (Thaut & 
Hoemberg, 2015). Emphasis within the study was not given to vocal performance ability, but to 
functional vocal behaviors. Most of the participants had a history of singing or playing a music 
instrument and had a mean age of 65 years. Inclusion criteria included no other neurological 
pathologies, no additional treatment for symptoms, such as deep brain stimulation, and the 
clients could not be professional or semi-professional musicians. During treatment, participants 
continued to take their regular dosage of dopamine repletion medication. The treatment measures 
included two speech tasks and two music tasks to compare differences between type of vocal 
usage. Measures were taken pre and posttest and randomly compared to the control group 
measures. Skilled assessors, neurologists and neurology students, listened to the speech and 
instrumental musical task recordings of both the treatment and control conditions and attempted 
to distinguish the two conditions from each other.   
Harris, Leenders, and de Jong (2016) reported that 8 out of 15 PD patients were identified 
as “probably or definitely” having PD. Two patients with PD were misidentified as healthy 
control participants. In the control group, eight participants were identified as “probably or 
definitely” healthy and one was misidentified as a patient with PD. The speech task of 
rhythmically reciting lyrics to a preferred song showed little difference between the treatment 
and control groups; however, the treatment group should have a more limited pitch range. There 
 24 
were not statistically significant differences found between the treatment and control groups in 
melodic tasks, and they were reliably distinguishable from each other according to aural 
perception of their speech. The results indicated that the majority of patients with PD exhibited 
slower speech rates than their controls, and greater pitch variability for the control group during 
the lyric recitation. The authors concluded that, as seen in gait training, musical behaviors are not 
affected by the neurological impairments apparent in PD. They suggest that the use of singing 
and music may help to improve the prosody of speech in individuals with PD. 
Music Therapy Studies. Haneishi (2001) investigated the use of music therapy vocal 
techniques on intelligibility with vocal acoustic measures in four women with ages ranging from 
67 to 77 years. The author also studied how these music therapy techniques would additional 
affect the mood of individuals with PD. The author developed the Music Therapy Voice Protocol 
(MTVP) as a pilot program that which utilized vocal and singing exercises with a focus on 
phonation and respiration to address speech intelligibility and vocal intensity. All participants 
had a diagnosis of PD and had reported symptoms of voice quality changes, reduced volume, 
impacted articulation, and difficulty breathing and none had previously received speech therapy 
services. In addition, the participants had no diagnosis of dementia. The protocol included 
opening and closing conversations, breath warm-up, vocal warm-up exercises, singing exercises, 
sustained vowel phonation, and speech exercises. Each participant underwent 12 to 14 MTVP 
session for a duration of 60 minutes, and pre- and posttest measurements. The treatment lasted 
for one month on average. Data were collected for speech intelligibility, vocal intensity, 
fundamental frequency, maximum vocal range, and the duration of maximum sustained vowel 
phonation. In addition to the vocal measures, an 11-point mood measure was administered pre- 
and posttest. The results indicated that the participants experienced increases in speech 
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intelligibility and vocal intensity from baseline to posttest. The mood measurements showed that 
there were positive reactions to the treatment; however, these findings were not statistically 
significant. The author suggested additional studies with larger sample sizes that account for 
variability and increase generalizability of the findings.  
Tamplin (2008) studied the effects of singing based vocal exercises on intelligibility and 
speech naturalness in 4 participants, ages 19-55, with dysarthria from traumatic brain injury or 
stroke. Inclusion criteria included dysarthria from acquired neurological damage, fewer than 18 
months post onset, and minimal difficulty in initiating speech and following directions. The 
treatment consisted of three 30-minute individual music therapy sessions per week for a duration 
of 8 weeks. The sessions included vocal exercises, oral motor respiratory exercises, rhythmic and 
melodic articulation exercises, rhythmic speech cueing, vocal intonation therapy, and singing 
three familiar songs. Assessment measure of speech intelligibility, rate of speech, and 
communication efficiency were taken pre-, mid-, and posttreatment was made using the Sentence 
Intelligibility Test and the Picture Description Task. The results showed a statistically significant 
improvement in speech intelligibility for the spontaneous speech task between pre- and posttest. 
Other results showed improvements in the measures, but no statistical significance. The author 
posited that the small sample size explained the lack of statistical significance. Effect size for the 
findings showed intriguing evidence of improvement in the measures. The author concluded that 
music therapy singing-based treatments were effective in improving speech intelligibility in 
spontaneous speech samples. The improvements in speech intelligibility may have been in part 
because of the use of rhythm to cue phrase lengths, and also in part because of the client’s 
awareness of the nature of the testing. This awareness might have increased tension in the pretest 
measurements and skewed pretest results. Oral and motor respiratory exercises increase 
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conscious control over automatic breathing patterns and might increase respiratory control 
through singing. Carry-over effects were seen posttreatment in clients’ everyday use of speech. 
The author suggested that further research is needed with larger sample sizes to increase the 
generalizability of these findings and distinguish between spontaneous speech and read speech 
intelligibility.  
Yinger and Lapointe (2012) adapted the Group Music Therapy Protocol (G-MTVP) 
developed by Haneishi (2001) and studied the effects of this adapted protocol on symptoms of 
voice disorders in people with PD. The study included 10 people with PD with ages ranging 
from 59–84 years. None of the clients experienced any type, timing, or dosage changes for 
medications during the treatment. The participants attended weekly 50-minute choir rehearsals 
for people with PD at a hospital over a 6-week period. Acoustic measurements of intensity, 
fundamental frequency, and fundamental frequency variability were taken pre- and posttest, and 
a self-report measure of mood. The interventions included introductory conversation, physical 
warm-ups, breathing exercises, speech exercises, vocal singing warm-ups, singing of preferred 
songs, and closing conversations with encouragement of at-home use of the techniques. The 
results of the study indicated a statistically significant increase in intensity from pre- to posttest 
measurements. Intensity of conversational speech also increased from pre- to posttest; however, 
these results were not statistically significant. The findings also indicated that there was no 
significant change in fundamental frequency from pre- to posttest measurements for both males 
and females. Fundamental frequency variability of conversational speech showed some 
increases.  However, the results were also not statistically significant. The authors recognize 
limitation to the study including small sample size and no control group. They also encouraged 
future studies with more gender balance and participants who have not participated in a 
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Parkinson’s choir prior to the study. The researchers concluded, that because of the degenerative 
nature of PD any improvement or maintenance of current functioning is important for this 
population. Furthermore, inclusion of caregivers within the choir help to promote cohesion and 
participation in leisure activities. Because of the prevalence of apathy for people with PD, leisure 
activity participation is incredibly important to reduce instances of symptoms of depression. The 
social and enjoyable nature of a Parkinson’s disease choir offers patients the opportunity to 
practice techniques to maintain current vocal functioning through neuroplasticity before impaired 
speech progresses to impairments in daily quality of life.  
Elefant et al. (2012) studied the effects of group singing and other voice interventions on 
signing and speech vocal abilities, and depressive symptoms in 10 people with PD with ages 
ranging from 55–84 years. All clients were assessed at Stage 2–3 on the Hoehn and Yahr 
Parkinson’s scale and were stable responders to Levodopa. The study utilized a single-group 
repeated measures design. Participants were divided into two equal size groups that received the 
same weekly 60-minutes intervention for 20 weeks. Collection of acoustic and self-reported data 
occurred at baseline, after 10 weeks of weekly music therapy, and after 20 weeks of weekly 
music therapy. Acoustic data measured fluency, mean pitch, pitch variability, vocal range, and 
mean intensity. Clients filled out the Vocal Handicap Index (VHI) to access how symptoms 
affected their daily lives and the Montgomery and Åsberg Depression rating scale to determine 
the severity of depressive episodes. The intervention included introductory conversation, 
breathing exercises, vocal exercises, singing of client preferred music, and closing conversation.  
The results from the Elefant et al. (2012) study showed that there were significant 
findings for the majority of variables in the singing measurements. Participants were found to be 
closer to singing the target note at the end of the study. Furthermore, loudness increased in the 
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second measurement as compared to baseline with decibel levels remaining stable. Voice range 
measures indicated there was no statistically significant changes from baseline to final 
measurement. According to the VHI findings, the physical subscale showed significant change 
from pre- to posttest measurements. Other results showed that the participants recognized 
functional improvements in their voices posttest; however, these findings were not statistically 
significant. The depression rating scale showed no significant changes; however, there were two 
outliers, which may have contributed to the stable mean change scores. The authors noted that 
there were no significant decreases in speech function during the treatment period, which might 
indicate that singing interventions help to maintain speech function. Increases in vocal intensity, 
consistency of vocal volume, pitch accuracy, and voice range support the initial hypothesis of 
improved vocal functioning post-treatment using music therapy. The authors concluded that the 
changes that contradict their initial hypotheses, could have been in part because of the less-
intense structure of this study (i.e., one weekly session instead of multiple weekly sessions and 
group setting instead of individual).  Larger carry-over effects also might have been found with 
increased vocal practice. The authors suggested a future randomized-controlled trial and 
increasing the frequency and duration of sessions to more directly investigate the effects of 
singing interventions compared to other treatment protocols.  The small sample size may have 
impacted the lack of significant findings related to the VHI and depression rating scale. The 
authors suggested larger sample sizes and different rating scales to address depressive symptoms 
in treatment.  
Ang, Maddocks, Zu, and Higginson (2017) reviewed current literature on the use of 
singing and wind instrument playing to improve respiratory functioning in people with long-term 
neurological diseases. Voice production requires the coordination of the respiratory system with 
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the laryngeal mechanism, as such, the use of wind instruments could help improve respiratory 
functionality. The authors found that there was a limited amount of randomized controlled 
studies available with this topic, so all studies found were included in the review. Measures of 
respiratory functioning included maximum inspiratory pressure, maximum expiratory pressure, 
sniff nasal inspiratory pressure, and spirometry measures such as forced expiratory volume, and 
forced vital capacity. The researchers utilized an adapted Cochrane review style and included 
five articles for review. There was a total of 109 participants in all studies, two randomized 
controlled studies, three pretest-posttest quasi-experimental studies, and two studies included 
people with PD. All studies spanned at least 12 weeks. Results from the studies showed that 
group voice and choral singing treatment showed statistically significant increases in maximum 
expiratory pressure and maximum inspiratory pressure. A study that included playing the 
recorder showed increases in vital capacity for two adults with PD. The authors concluded that 
the five identified studies utilizing singing or wind instrument interventions showed 
improvements in respiratory function for people with long-term neurological conditions. The 
authors also noted that the study showing improvements in vital capacity for people with 
Parkinson’s disease did not include the effects on functional outcomes for the participants. 
Because of this, it is unclear if the improvements seen in the results were beneficial to daily 
functioning. Intervention dosages, complexity of interventions, and study architecture varied 
across studies and may indicate the need for further research. Further research into the 
effectiveness of systematized singing and wind instrument interventions is needed to further the 
understanding of the effectiveness of these interventions on people with long-term neurological 
conditions, such as PD. 
 30 
Tamplin et al., (2019) studied the effects of a singing-based therapy on vocal intensity, 
maximum phonation time, expiratory and inspiratory pressure, and voice-related quality of life in 
people with PD. Weekly and monthly singing interventions were compared to weekly and 
monthly active control groups. There were 75 participants in the study with an average age of 74 
years. It is important to note that this study was a 3-month check-in for yearlong intervention 
protocol. The participants were not randomly assigned to their conditions and chose which 
activity they wished to pursue. The singing condition involved 30 minutes of high intensity vocal 
exercises to target respiratory control and vocal loudness, among others. Participants then spent 
60 minutes engaging in singing of popular and traditional songs. At the conclusion of each 
session, participants engaged in social interaction and peer conversation. Weekly singing 
interventions were facilitated by board certified music therapists and speech pathologists, while 
the monthly group facilitated volunteer musicians with training in the intervention protocol. Both 
the monthly and weekly groups receive the same treatment protocol. The weekly control group 
attended painting, dancing, or tai chi sessions, and the monthly controls group participated in a 
monthly peer support group. Results showed that participants in the weekly singing group had 
higher scores for vocal intensity and a decrease in negative emotions about their voice problem 
according to the voice-related quality of life questionnaire when compared to the monthly 
singing group and control groups. The weekly singing condition also experienced an increase in 
expiratory pressure, indicating a correlation between expiratory pressure and vocal intensity. The 
authors suggested that future studies employ randomization of participants to conditions. They 
also suggested that both the monthly and weekly conditions be facilitated by fully qualified 
facilitators (Tamplin, et al., 2019). 
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Neurologic Music Therapy 
Azekawa and LaGasse (2018) investigated the effectiveness of Neurologic Music 
Therapy (NMT) interventions to address voice deficits in five people, ages 57–81 with 
hypokinetic dysarthria, as seen in PD. All participants had typical hypokinetic dysarthria 
characteristics, such as reduced volume of speech, monotone pitch, reduced stress in speech 
pattern, breathy and hoarse voice quality, imprecise articulation, and a varied rate of speech, 
which is common with PD. All participants had a current diagnosis of PD and no co-morbidity 
with other neurological impairments or cognitive deficits. A pre-intervention questionnaire was 
distributed to all participants to determine client preferred music, and musical history. A brief 
interview also was conducted to determine important demographic information about the 
participants’ disease experience. Three speech tasks were administered pre- and post-
intervention to determine changes in vocal functioning, voice quality, articulatory control ability, 
and connected speech intelligibility. The study included weekly 50-minute group music therapy 
treatments for a duration of 6 weeks. The sessions included warm-up stretches, Vocal Intonation 
Therapy, Therapeutic Singing, and closing stretches. The results indicated that maximum 
phonation time, voice quality, and articulatory control either improved or maintained levels 
compared to pre-test measurements. It is important to note that because of the degenerative 
nature of PD a result of maintaining current functioning is important. Measures of connected 
speech intelligibility indicated a significant difference between pre-post difference for pause 
time. Statistical analysis also showed a large effect size for the maximum phonation time 
measurements. Anecdotally, the authors reported that participants expressed a desire to continue 
treatment poststudy and had frequent positive statements about the treatment protocol. Maximum 
phonation time had the greatest pre-post improvements and one male client showed 
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improvements to the point that he was approaching normal phonation time. Statistically 
significant positive changes in speech pauses and connected speech intelligibility were also 
found. The authors reported that further research is needed with larger sample sizes and a control 
group to determine the true effectiveness of this treatment and that additional at-home exercises 
between sessions might help to increase the benefits found in this study. 
Perceptual Analysis 
The Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V; ASHA, 2006) is a 
short perceptual clinical evaluation of voice to rate overall severity, roughness, breathiness, 
strain, pitch, and loudness. The measurements are based on a visual analog scale with measures: 
not deviant, mildly deviant, moderately deviant, and severely deviant. The metric is also used as 
a visual analog scale, as a clinician marks on the line and measures the gradation of the disorder 
using location of the marks as measured by millimeters. Higher scores are indicative of more 
disorder, with the highest possible score of 100. A determination of the presence of a disorder is 
will be determined to be consistent or intermittent, based on the voice sample collected at the 
screening meeting. The CAPE-V was chosen for this study because its interrater reliability scores 
were slightly higher when compared to another perceptual measure. Furthermore, the CAPE-V 
has been found to have empirical validity. The measure was also chosen because of its clear 
protocol and ability to measure conversational speech and differing voice contexts. (Zraick, R. et 
al., 2011). A study comparing the reliability of the CAPE-V rating system to another called the 
GRBAS found that the CAPE-V had high reliability when rating dysphonia in clients with 
impairment and their healthy controls (Karnell et al., 2006). 
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Self-Report Measure 
The Voice-Related Quality of Life (V-RQOL; Hogikyan & Sethuraman, 1999) is a 10-
item self-report Likert-scale questionnaire that determines the level of a client’s self-perceived 
voice disorder and its impact on quality of life. Scores range from 0 to 100 with higher scores 
indicative of a higher level of perceived severity of voice disorder. The current 10-item 
questionnaire was found to have strong internal consistency and reproducibility, indicating its 
reliability, and also clear construct validity. This measure was chosen because of its sensitivity to 
self-perceived voice related issues over general health measures and its measured reliability and 
validity. A study comparing the V-RQOL and a separate self-report measure of voice functioning 
found that the V-RQOL total score had a better representation of how the client perceives their 
voice and its impact on their daily life compared to the other self-report measure (Karnell et al., 
2006).  
The Vocal Handicap Index (VHI) is a 30-item Likert-scale questionnaire with sub-scales 
in the functional, emotional and physical domains (Jacobson et al., 1997). The questionnaire was 
developed to measure the impact of a person’s voice disorder on their daily activities, their 
emotional responses to their voice disorder, and any physical changes that had occurred because 
of the voice disorder. The test has strong test-retest reliability and the study by Jacobson et al., 
indicated that the participants of the study indicated that the questionnaire increased their 
awareness of the implications of their voice disorders. In a recent study measuring the 
effectiveness of the VHI to measure the psychological impact of voice changes associated with 
Parkinson’s disease found that the questionnaire was a consistent and reliable tool with the PD 
population (Guimaraes, Cardoso, Pinto, & Ferreira, 2017). A study of the relationship between 
Parkinson’s disease and scores in aerodynamic measures and the VHI (Motta, Cersari, 
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Paternoster, Motta, & Orefice, 2018) found that the 15 male participants diagnosed with PD 
reported statistically significant increases in scores on the VHI when compared to healthy adults.  
Summary 
Individuals with PD have significant decreases in pitch range (Ikui et al., 2014), and 
decreased laryngeal functioning (Smith et al., 1995) specifically affecting the intrinsic and 
extrinsic muscles in the laryngeal framework (Matheron et al., 2017). Singing directly engages 
the muscles of the laryngeal mechanism (Sapienza & Ruddy, 2018, pp. 21-58). While traditional 
speech-language pathology interventions (Simberg et al., 2012; De Angelis et al., 1997), and Lee 
Silverman Voice Treatment (Dromey et al., 1995; Sackley et al., 2018) can be effective in 
treating voice disorders and improving vocal functioning, music therapy can also address these 
speech needs and physical changes (Harris et al., 2016). Singing-based interventions (Haneishi, 
2001; Tamplin, 2008) and respiratory exercises (Ang et al., 2017) have also been shown to 
improve speech intelligibility, and vocal acoustic measures in people with PD and other 
neurological conditions. Less intensive singing interventions have not been as effective as other 
vocal rehabilitation therapies (Shih et al., 2012), however, improvement or maintenance of 
symptoms are still apparent. Group singing has been shown to positively impact both vocal 
rehabilitation in people with PD (Elefant et al., 2012). Neurologic music therapy techniques have 
recently demonstrated the unique ability of music-based interventions to improve maximum 
phonation time, voice quality, and articulatory control in people with PD (Azekawa, & LaGasse, 
2018; Tamplin, et al., 2019). Music therapy can offer a unique combination of singing and 
respiratory therapies to address rhythm, respiration, and phonation in the treatment of individuals 
experiencing voice disorders results from PD. Further research is needed to develop a 
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standardized treatment protocol for singing based therapies to determine its true effectiveness on 
voice disorders from PD.  
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Chapter Three 
Method 
This chapter will describe the research design, participants, procedure, and music therapy 
intervention to be used for addressing the research questions. The measures and data analysis 
will be discussed and outlined.  
Research Design 
This study was an exploratory analysis employing single-group repeated measures for 
hypothesis testing.  Data collection of acoustic measures and self-report measures were collected 
before and after a music therapy protocol using NMT techniques. The independent variable was 
the NMT protocol. The dependent variables included acoustic, perceptual, and quality of life 
metrics related to speaking voice.  
Participants from Specific Aim 1, 2, and 3 
There were six community-dwelling participants diagnosed with PD who reported 
experiencing voice changes within the past year. Volunteers were recruited through a local 
community Parkinson’s disease support group, or from referral from local speech-language 
pathologists. This sample was limited leading to possible sampling bias based on the 
convenience of inclusion. Inclusion criteria included: 
1. Diagnosed with Stage 2 or 3 PD based on the Hoehn and Yahr scale (Hoehn & Yahr, 
1967). Information about participants’ rating score was obtained through a signed 
Release of Information form giving permission for the researcher to contact their 
neurologist 
2. No previous music therapy services to address speaking voice 
3. Willing to sing to participate in a vocal protocol utilizing NMT techniques 
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4. English as first language 
5. Age range of 45-80 years old 
6. No reported co-morbidity of a respiratory disorder/disease 
7. Ability to follow 2-3 step commands without repetition 
8. Not currently receiving speech-language pathology services 
Exclusion criteria include: 
1. Diagnosed with Stage 4 PD based on the Hoehn and Yahr scale 
2. Currently receiving speech-language pathology or music therapy to address voice 
disorders 
Participant #1: Brian 
Brian is a 78-year-old man diagnosed with Stage 3 Parkinson’s disease according to the 
Hoehn and Yahr scale. He presented with minimal essential tremor in his right hand. Brian 
reported that he had noticed changes in his vocal range and a lowering of his voice over the past 
few years. He reported a history of music experience including singing lessons, playing the 
guitar and piano, and performing in musicals and at church. His musical preferences included 
country, rock and roll, jazz, and religious music.  
Participant #2: Roy 
 Roy is a 75-year-old man diagnosed with Stage 3 Parkinson’s disease according to the 
Hoehn and Yahr scale. He presented with a soft-spoken voice, shuffling gait, and slumping of the 
shoulders and upper back. Roy reported his voice had become increasingly soft as the disease 
progressed. Roy stated that he continues to work as an engineer and presents regularly at 
conferences. He has a history of playing percussion and piano. His musical preferences include 
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praise and worship music, children’s songs to play with his grandchildren, and some classical 
music.  
Participant #3: Jake 
 Jake is an 80-year-old man diagnosed with Stage 2 Parkinson’s disease. He presented 
without tremor, reported a reduction in vocal volume, and a slight shuffling gait. Jake reported 
that he has no history of playing a musical instrument or singing, but he enjoys country and old-
time music, especially that of Burl Ives. He reported that his favorite activity is gardening, which 
has become increasingly difficult because of the disease progression.  
Participant #4: Daniel 
 Daniel is an 80-year-old man diagnosed with Stage 3 Parkinson’s disease. He has a love 
of listening to classical music and hymns, especially “Beautiful Savior,” and used to work as a 
pastor. Daniel received the Lee Silverman Vocal Technique in previous years and experienced a 
positive change in vocal functioning while receiving the treatment, but it was difficult to 
maintain the positive effects after treatment ended. He presented with impairments in 
articulation, breath control, and his chart reported impairment in cognitive functioning. He also 
experiences significant rigidity and difficulty with balance and walking. He has diplopia and 
oropharyngeal dysphagia. Daniel received music therapy treatment sessions in his residence with 
his wife present.  
Participant #5: Clint 
 Clint is a 69-year-old man with a diagnosis of Stage 2 Parkinson’s disease. He presented 
with bilateral tremor when reaching and resting tremor in right hand. He reported that he has 
difficulty processing new information. Clint stated that his vocal intensity fluctuates throughout 
the day, and he has difficulty being heard after prolonged use of his voice. His musical 
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preferences include Motown and music from the 1950’s and 1960’s. Clint also reported feelings 
of anxiety, especially when trying new things.  
Participant #6: Josh 
Josh is a 69-year-old man with a diagnosis of Stage 3 Parkinson’s disease. He presented 
with tremor on the right side, difficulty with balance, rigidity, oropharyngeal dysphagia with 
decreased secretion management. He also had instances of dyskinesia which made it difficult to 
obtain the final measurements for this study. His wife was present for all study intervention 
sessions. His voice was quiet in volume and had imprecise articulation leading to decreased 
conversational intelligibility. He previously worked in agriculture and reported that the disease 
has taken away a lot of his previous functionality. During the first study intervention session, 
Josh became visibly upset and teary-eyed when speaking about the functionality he had lost 
because of the disease. Josh reported he enjoyed music from the 1950’s and 1960’s and has 
never played an instrument or taken singing lessons. 
Procedure 
Volunteers participated in an initial screening meeting at which time they were informed 
about the purpose of the study and provided with an informed consent document (Appendix A), 
detailing the risks and benefits of the proposed treatment, reasonable alternative treatments, and 
consequences of no treatment. The document included full disclosure of the nature of the 
research and the expected involvement of the participant. The explanation of the research was 
presented in easily understood terminology to improve comprehension. Participation in the study 
was voluntary after informed consent had been established, and participants were informed that 
they could freely cease or refuse treatment at any time. Participants were encouraged to ask 
questions about the study and all concerns were addressed thoroughly. Participants were 
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provided with information about confidentiality practices and data management. Participants 
were also informed of the study protocol regarding audio or visual recording. A Release of 
Information form was be provided for their signature so the researcher could contact each 
individual’s provider. Participants performed the V-RQOL to determine self-perceived effects of 
their voice changes. Last, a voice recording was gathered from each participant for analysis use 
the CAPE-V by a research team speech-language pathologist. After the screening meeting 
determined inclusion in the study, acoustic measures were taken at the Communication Disorders 
Clinic at Appalachian State University to determine baseline vocal functioning.  
Clients received one individual 60-minute music therapy session each week for 6 weeks. 
The number of weeks was chosen after reviewing suggestions from previous research and based 
on client availability. Sessions took place in the Interdisciplinary Clinic at Appalachian State 
University in Boone, North Carolina. In addition, clients were given 10–15 minutes of 
homework after each session to encourage transfer into daily life.  
Post-intervention, a secondary recording was obtained for blind-rating by a research team 
speech-language pathologist using the CAPE-V measurement tool. Acoustic measures were 
taken again, and data were compared to pre-intervention measurements. The VHI and the V-
RQOL were also re-administered and compared to pre-intervention measures.  
Music Therapy Intervention Protocol Utilizing NMT Techniques 
The Music Therapy Intervention protocol is presented in Table 1.  
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Table 1 
Neurologic Music Therapy Protocol 
Technique Description Length 
Introductory Conversation Progress on homework and any perceived 
vocal changes as well as general well-being of 
participant will be discussed.  
 
5 minutes 
Vocal Intonation Therapy (VIT) Physical warm-ups and 4-point grounding 
through music: Gentle movement of the torso, 
neck, and facial muscles with emphasis on 
relaxation of the jaw and neck and use of the 
diaphragm and abdominal muscles. Four-
point grounding emphasizes proper posture 
and support of the respiratory system.  
 
Breathing exercises and music: The 
participants were asked to breathe deeply 
through the nose attending to the abdominal 
muscles by placing their hands on the 
abdomen while inhaling and exhaling for 
immediate feedback. Roman vowel breathing 
to promote full inhalations was utilized.  
 
Articulation exercises and music (5 minutes): 
Rhythmic speaking through commonly 
known tongue twisters to coordinate 
articulators (tongue, lips, jaw), breath, and 
phonation.  
 
Vocal warm-ups: These exercises included 
gentle sirens from highest pitch to lowest 
pitch, yawning while vocalizing, glissandi, 
both ascending and descending, and 
ascending and descending octaves on /a/. Use 
of the articulators with phonation will be used 
to increase awareness of articulation.  
 
18 minutes 
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Table 1 (continued.) 
  
Measures 
 Acoustic Measures  
Acoustic measures were captured using voice samples of isolated vowels, words, sentences, and 
paragraphs before and after the intervention. Measurements were captured using the Pentax 
Medical Computerized Speech Lab Model 4150B hardware with the Multi- Dimensional Voice 
Program (MDVP) Version 4.0 analysis software (PENTAX Medical, Montvale, New Jersey, 
USA). Measurements were compared to normative data and analyzed for change based on sex 
and age to determine clinically significant changes within each patient. Acoustic variables 
collected are found in Table 2.  
  
Therapeutic Singing (TS)   
 
Singing one to three client-preferred songs 
with emphasis on clear articulation and 
phrasing through breath and phonation 
coordination. Songs chosen included key 
phrases chosen by the client and therapist to 
address specific communication goals and  
specific keys will be chosen based on clients 
comfortable singing range. 
 
15 minutes 
Oral Motor and Respiratory 
Exercises (OMREX) 
Harmonica playing of 2 to 3 client preferred 
songs to promote breath support and 
controlled exhalation.  
 
10 minutes 
Relaxation and Transition  Short cool-down exercises helped relax the 
voice after treatment. When necessary, a short 
music-assisted relaxation was offered if 
excess bodily tension or tremor was observed 
during the session. 
 
5 minutes 
Closing Conversation Assigned homework and strategies for using 
interventions during daily life are discussed.  
 
2 minutes 
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Table 2 
Acoustic Measure Table with Descriptions and Norms 
Task Measures Normal Values for 
Males Ages 65-80* 
Clinical Significance 
Sustained Vowel /a/: 
Jitter  % .589 + .535 Increased jitter, as an 
indicator of cycle-to-
cycle variation of 
fundamental frequency, 
indicates the presence of 
vocal pathology.c  
 
Shimmer (%) % 2.523 + .997 Shimmer is the cycle-to-
cycle variation of voice 
waveform amplitude. 
When increased, it also 
indicates the presence of 
vocal pathology.d 
 
F0 – Tremor Frequency 
(Fftr) 
Hz 3.655 + 3.731 This parameter 
measures the long-term 
frequency modulation of 
the fundamental 
frequency. People with 
PD demonstrate 
significantly higher Fftr 
scores than control 
groups.e 
 
Maximum Phonation 
Time 
Sec >20 sec Increased maximum 
phonation time from 
pre- to post-test 
indicates improved 
functionality of the 
respiratory system.  
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 Table 2 (continued.
Sustained Vowel /i/ 
Maximum Phonation 
Range  
Low 140.418+23.729 
Decreased phonatory F0 
range indicates a 
reduction in useable 
vocal range and could 
be indicative of a voice 
disorder. 
 
High 150.080+24.362 
Standardized Reading Passage: Rainbow Passage 
Mean Fundamental 
Frequency (F0) 
Hz 141.743+21.136 Increased variability 
may be an indication of 
a voice disorder from 
Parkinson’s disease.f 
 
Mean F0 Range (PFT)  Semitones 2.095+1.064 Mean fundamental 
frequency range in 
semitones is the measure 
of the fundamental 
frequency pitch 
variability available to 
an individual. People 
with PD present with 
significantly reduced 
variability when 
compared to healthy 
controls.g 
 
Mean Intensity dB .311+.139 Average loudness, when 
impaired, indicates 
decreased control of the 
respiratory muscles 
necessary to produce 
volume.  
 
S/Z  Ratio   The s/z ratio compares 
expiratory control 
during an unvoiced 
consonant to sustained 
phonation on a voiced 
consonant. An increased 
score on the s/z ratio can 
indicate the presence of 
vocal pathology because 
of the inefficiency of the 
vocal fold adduction.h  
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Table 2 (continued.)  
* Normative values for acoustic measures obtained from Pentax Medical Computerized Speech 
Lab Model 4150B hardware with the Multi- Dimensional Voice Program (MDVP) Version 
4.0 analysis software (PENTAX Medical, Montvale, New Jersey, USA) 
a Han, Yun, Chong, & Choi, 2018 
bArffa, Krishna, Gartner-Schmidt, & Rosen, 2012 
c Sapienza & Ruddy, 2018, p. 447 
d Sapienza & Ruddy,, p. 454 
e MacCallum, Zhang, & Jiang, 2010 
f Bowen et al., 2013 
g Bowen et al., 2013 
h Eckel & Boone, 1981 
i Hogikyan & Sethuraman, 1999 
j Jacobson, Johnson, Grywalski, Silbergleit, Jacobson, Benninger, 1997 
k Zraick, Kempster, Connor, Klaben, Bursac, Glaze, 2011 
 
    
Voice-Related Quality 
of Life (V-RQOL) 
 59.1+ 20.2a The V-RQOL is a 10-
item self-report measure 
of vocal functioning 
with sub-categories in 
the physical, emotional, 
and functional domains.i 
 
Vocal Handicap Index 
(VHI) 
 2.83+3.93b The VHI is a 30-item 
self-report measure of 
vocal functioning with 
sub-categories in 
functional, physical, and 
emotional domains.j 
 
Consensus Auditory- 
Perceptual Evaluation 
of Voice (CAPE-V) 
  The CAPE-V is a 
clinician’s perceptual 
evaluation of an vocal 
impairment based on 
perceived overall 
severity, roughness, 
breathiness, strain, 
loudness, and pitch.k 
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 Perceptual Analysis. A blind rating of the Consensus Auditory-Perceptual Evaluation of 
Voice (CAPE-V; ASHA, 2006) was performed at pre-intervention and post-intervention by an 
experienced speech-language pathologist in the Communication Disorders Department at 
Appalachian State University.  
Self-Report Measure. The Voice-Related Quality of Life (V-RQOL; Hogikyan & 
Sethuraman, 1999) and the Voice Handicap Index (Jacobson et al., 1997) were administered 
during the screening meeting and post-intervention.  
Data Analysis 
Non-parametric statistics were conducted using a paired sample Wilcoxon Sign Ranks 
test for two dependent measures for each measure was administered to determine if statistical 
significance was present for each hypothesis (p  0.05). Any findings resulting in statistical 
significance (p < .05) was not generalizable based on no statistical significance, but could be 
used to inform future research with this particular population. Effect size (r) indicates the 
relationship between the independent variable (NMT intervention) and the dependent variable 
(acoustic, perceptual, and self-report measures). The effect size indicates the level to which the 
treatment worked to affect the variables. A significant effect size is closer to one; meaning, r= 
.02 is a small effect size, r = .5 is a medium effect, and r = .9 is a large effect. Numerical data 
were presented in graph and table form. Tabular and graphical representation of the data are 
presented based on the American Psychological Association guidelines outlined in the 
Publication Manual of the American Psychological Association, 6th Edition. 
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Chapter Four 
Results 
This chapter presents the results of the acoustic, perceptual, and self-report measures of a 
Neurologic Music Therapy protocol to improve speaking voice in individuals with Parkinson’s 
disease. The specific aims of the study were threefold: 
1. Scores for the acoustic measures of tremor at fundamental frequency (F0), percent 
jitter and shimmer, F0 variability would decrease indicating increased vocal stability, 
that there would be an increase in maximum phonation time, range of F0, average 
intensity, as well as decrease in average F0 indicating increase vocal flexibility, that 
participants would maintain an S/Z ratio of less than 1:4 indicating no vocal 
pathology.  
2. Scores for the perceptual measure of the total CAPE-V would decrease indicating an 
increase in perceived vocal quality. 
3. Scores for the self-report scores for the total VHI and total V-RQOL would decrease, 
indicating a decreased effect voice impairment in daily life and increased voice-
related quality of life, respectively.  
Participant Flow 
 There were six participants recruited for this study. All participants received a music 
therapy protocol using NMT technique designed to strengthen speaking voice over the course of 
6 weeks. All six participants received six 1-hour sessions with the music therapy protocol. There 
was no instances of attrition.  
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Recruitment 
Volunteers were recruited during the first quarter of the year by presenting an 
informational session at a local community Parkinson’s support group meeting. Pamphlets were 
shared with the group members and interested volunteers were invited to contact the investigator 
by phone or email. Volunteers who responded were contacted within one week for eligibility 
screening. Six participants met the criteria for the study and consented to enrollment. 
Participants 
All participants were men and had an average age of 75 years (range 69–80). All 
participants were diagnosed with typical PD with scores of 2 or 3 on the Hoehn and Yahr Scale 
(Hoehn & Yahr, 1967) and expressed experiencing voice changes due to their disease. 
Participants had a median score of 2.5 on the Hoehn and Yahr scale. Participants were not 
currently receiving music therapy or speech language pathology services to address voice 
changes and had no co-morbidity of respiratory disease or disorder. No medication changes were 
reported during treatment.  
 Demographic information is presented in Table 3. Fundamental differences between 
participants on this study were achieved through therapist observations and case history 
information. All names presented have been changed to maintain confidentiality.  
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Table 3 
Demographic Information 
  
 
 
 
 
 
 
 
a Hoehn & Yahr, 1967 
 
Statistics and Data Analysis 
Acoustic measures. A Wilcoxon signed-rank test was conducted to determine the effect 
of the intervention on individuals diagnosed with Parkinson’s disease. Acoustic measurements of 
tremor frequency, jitter, shimmer, fundamental frequency variability, maximum phonation time, 
maximum phonation range in hertz and semitones, mean intensity, and s/z ratio. Scores for 
shimmer (%), F0 tremor frequency (Fftr; Hz), maximum phonation time (MPT; seconds), 
maximum phonation range low (Hz), mean F0 (Hz), mean F0 range (semitones), and s/z ratio 
failed to meet assumptions for normal distribution; therefore, the researcher used nonparametric 
statistics. See Table 4 for a presentation of medians, ranges and statistical data from pre-
intervention to post-intervention. 
Participants (n = 6) Age (years) Sex Hoehn and Yahr Scorea 
Brian 78 Male 3 
Roy 75 Male 3 
Jake 80 Male 2 
Daniel 80 Male 3 
Clint 69 Male 2 
Josh 69 Male 3 
Commented [CPL1]: I edited this sentence 
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Table 4 
 
Medians, Ranges, and Wilcoxon Signed Ranks Test for Acoustic Measures for all Participants 
Dependent Measures Pre-Intervention   Post-Intervention  Wilcoxon Signed Ranks Test 
Mdn Range  Mdn Range  Z p (2-tailed) r 
Jitter (%) 2.08 0.92–3.49  2.71 0.55–6.63  -.73a .46 .21 
Shimmer (%) 4.28 2.57–9.16  5.17 3.58–27.40  -1.15a .25 .44 
 Fftr (Hz) 5.31 3.35–6.82  5.33 3.29–11.11  -.94a .35 .27 
MPT (sec.) 21.86 6.09–28.36  19.06 8.16–24.37  -.52b .60 .15 
MPR Lowest Note (Hz) 427.65 155.56–622.25  469.32 185.00–436.25  -1.46a .14 .53 
MPR Highest Note (Hz) 104.00 73.41–116.54  110.00 82.41–130.81  -1.83a .07 .42 
Mean F0 (Hz) 123.92 108.54–152.99  125.43 105.38–155.71  -.11
a .92 .03 
Mean F0 Range (Semitones) 20.00 17.00–26.00  20.00 17.00–30.00  -.41
a .68 .12 
Mean Intensity (dB) 52.69 50.69–60.46  52.80 50.37–56.07  -.31a .75 .09 
s/z Ratio 0.81 0.52–0.89  0.90 0.43–1.31  -1.08a .28 .31 
Note 
a  Wilcoxon Signed Ranks Test 
b Based on negative ranks 
c Based on positive ranks 
d The sum of negative ranks equals the sum of positive ranks.
 50 
All of the acoustic variables except the maximum phonation range highest note yielded 
no statistically significant median change (=.05) from pre-intervention to post-intervention 
testing based on the Wilcoxon Signed Ranks Test. Reference Table 4 for z-scores, p-values, and 
effect sizes.  
Of the six participants recruited to the study, two participants saw a decrease in their 
percent jitter and percent shimmer compared to the four participants who saw increases; 
however, this decrease was not statistically significant. Three participants had a reduction in 
tremor frequency. Four participants experienced a reduction in maximum phonation time. Four 
participants saw an improvement in maximum phonation range high and two participants 
maintained levels of maximum phonation range high from pre-intervention to post-intervention 
testing. Two participants’ maximum phonation ranges remained the same. Half of the 
participants saw a decrease in their mean intensity. Of particular note, Participant #6 (Josh) 
experienced a dyskinetic event during final testing caused by turning off his deep brain 
stimulator for an appointment before attending his study sessions that day. It is possible that the 
excess dyskinesia affected the accuracy of his post-intervention data.  
Perceptual measures. A rating of the Consensus Auditory-Perceptual Evaluation of 
Voice (CAPE-V; ASHA, 2006) was completed pre-intervention and post-intervention by an 
experienced speech-language pathologist in the Communication Disorders Department at 
Appalachian State University. Deidentified recordings of each participant were analyzed.  
CAPE-V measurements can result in scores for subdomains in roughness, breathiness, strain, 
pitch, and loudness, as well as an overall severity of vocal functioning. Participant #4 (Daniel) 
had increased scores for roughness and strain from pre-test to post-test. Participant #2 (Roy) and 
Participant #6 (Josh) also had increased scores for strain. There were median group decreases in 
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scores for roughness (mdn  = 19.5), breathiness (mdn  = 21.5), physical (mdn  = 16.5), and 
loudness (mdn  = 35.5). The median score for strain increased from 6.5 to 8.0 (out of 100) 
indicating increased perceived strain (worsening) in the voice. The overall severity median score 
reduced by 32.5 indicating that the overall severity of the client’s voices decreased (improved).  
 The Wilcoxon Signed Rank test was used to determine statistical significance of the 
median changes. Breathiness, pitch, loudness, and overall severity yielded statistically significant 
median changes (p < .05) indicating an overall perceived improvement in vocal functioning. The 
median changes for roughness and strain were not statistically significant. Table 5 outlines the 
median, ranges, z-score, p-values, and effect sizes for perceptual measures.
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Table 5 
 
Perceptual Measures Test Statistics 
 Pre-Intervention  Post-Intervention   Wilcoxon Signed Ranks Test 
mdn Range  mdn Range  Z p (2-tailed) r 
Roughness 20.5 1.0–59.0  1.0 0.0–57.0  -1.53b .25 .33 
Breathiness 48.0 12.0–85.9  26.5 10.0–50.0  -2.201b .03* .64 
Strain 6.5 1.0–41.0  8.0 1.0–28.0  -.106a .92 .31 
Pitch 23.5 4.0–36.0  7.0 0.0–23.0  -2.201b .03* .64 
Loudness 55.5 27.0–92.0  20.0 2.0–47.0  -2.201b .03* .64 
Overall Severity 57.5 13.0–90.0  25.0 11.0–61.9  -2.201b .03* .64 
Note. 
a Based on negative ranks 
b Based on positive ranks 
* Denotes p < .05 
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Self-Report measures. A Wilcoxon signed-rank test was conducted to determine the 
effect of the intervention on self-report measures of vocal handicap and voice-related quality of 
life for the participants. The VHI and the V-RQOL were administered pre-intervention and post-
intervention and median changes were compared and analyzed to measure effectiveness of the 
treatment. Table 6 outlines the medians, ranges, and effect sizes for the subcategories and total 
scores of the VHI, and the Wilcoxon Signed Ranks Test results.  
The Vocal Handicap Index (VHI) was administered pre-intervention and post-
intervention and includes subcategories in the functional, physical, and emotional domains, as 
well as a total score. A Wilcoxon Signed Ranks test was used to determine statistical 
significance. One participant reported a reduced score in the functional and physical domains 
from pre-intervention to post-intervention, indicating that this participant perceived an 
improvement in their perceived physical and functional abilities. Median scores for the 
functional domain had a negative change (mdn  = 2.50). The physical domain (mdn  = 3.50) 
and social domains (mdn  = 5.00) had a similar increase in scores from pre-intervention to post-
intervention testing. The total scores yielded a median increase of 9.50 from pre-  
(mdn  = 49.50) to post-intervention (mdn  = 59.00), however, this difference was not found to 
be statistically significant.  Table 6 outlines the medians, ranges, and test statistics for the 
subcategories of the VHI. 
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Table 6 
 
VHI Medians, Ranges, and Test Statistics for all Participants 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note.  
a Based on negative ranks 
b Based on positive ranks 
c The sum of negative ranks equals the sum of positive ranks 
 Pre-Intervention Post-Intervention Wilcoxon Signed Ranks Test 
mdn Range   mdn Range  z p (2-tailed) r 
Functional 17.5 8.0–30.0   19.0 11.0–33.0  -1.89a .06 .03 
Physical 17.5 8.0–29.0   21.0 13.0–28.0  -1.80a .07 .52 
Emotional 14.5 1.0–28.0   19.5 3.0–26.0  -1.48b .14 .03 
Total 49.5 17.0–82.0   59.0 27.0–83.0  -1.48a .14 .43 
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The Voice-Related Quality of Life (V-RQOL) questionnaire was administered with 
domains in physical and social functioning. Within the social domain, there were four 
participants’ score that decreased, one participants’ scores that increased, and two participants’ 
scores that remained the same. Within the physical domain, two participants’ scores increased 
and four participants’ scores decreased from pre-intervention testing to post-intervention testing, 
indicating they perceived a reduction in the impact of their disease on their physical quality of 
life. The total score had four decreases and two increases. A Wilcoxon Signed Ranks test was 
performed to determine the statistical significance of the intervention on scores for the V-RQOL. 
The social and physical domains both yielded overall nonsignificant reductions in median scores, 
with the social domain showing a greater reduction (mdn  = 9.38) than the physical domain 
(mdn  = 6.25). The total median score also reduced from pre-intervention to post-intervention 
(mdn  = 8.75). This change, however, did not reveal a statistically significant difference  
(p < .05). No statistically significant differences were found for any of the domains from pre-
intervention to post-intervention. Table 7 outlines z-scores, p-value, and effect sizes.  
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Table 7 
 
V-RQOL Medians, Ranges, and Test Statistics 
 Pre-intervention Post-intervention  Wilcoxon Signed Ranks Test 
Mdn Range  Mdn Range  z p (2-tailed) r 
Social 84.38 31.25-100  75 6.25-100  -1.1b .27 |.31| 
Physical 68.75 16.67-83.33  62.5 41.67-87.5  .00c 1 |0| 
Total 75 22.5-90  66.25 27.5-92.5  -.11b .92 |.03| 
Note.  
a Based on negative ranks 
b Based on positive ranks 
c The sum of negative ranks equals the sum of positive ranks 
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Chapter Five 
Discussion 
 The purpose of this study was to explore how a music therapy protocol using NMT 
techniques impacts th speaking voice and quality of life in individuals with PD based on 
acoustic, perceptual, and self-report measures collected pre-intervention and post-intervention. 
The use of NMT has been used to improve gait in people diagnosed with Parkinson’s; however, 
there is little research on its effectiveness to address voice changes. By utilizing a series of 
Neurologic Music Therapy interventions, the researcher hoped to promote respiratory strength 
and vocal functioning. Acoustic, perceptual, and self-report measures were administered pre-
intervention and post-intervention to measure their vocal functionality, the perception of their 
vocal functioning according to a third-party rater, and the impact of their vocal impairments 
participants’ daily life. This chapter will discuss the findings, their possible impact on vocal 
functioning in people with PD, future implications and recommendations for music therapy 
research and clinical practice, and limitations to the current study. The specific aims of the 
research will serve organize the discussion.   
Specific Aim 1: To examine the effects of NMT techniques on voice production following an 
8-week treatment period as measured by acoustic variables. 
 It was hypothesized that scores for the acoustic measures of tremor at fundamental 
frequency (F0), percent jitter and shimmer, F0 variability, maximum phonation range low and 
average fundamental frequency (F0) would decrease indicating increased vocal stability and 
variability. It was also hypothesized that maximum phonation time (MPT), fundamental 
frequency in semi-tones, maximum phonation range high and average intensity scores would 
increase from pre-intervention to post-intervention. There were no statistically significant 
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differences found between pre-intervention and post-intervention acoustic measures except for 
the maximum phonation range high.  
Mean scores for tremor at fundamental frequency remained relatively stable suggesting 
that the intervention may have helped to maintain the participants long-term frequency 
modulation of the fundamental frequency. It is also possible, however, that the short treatment 
period may also have prevented the scores from improving further. The degenerative nature of 
Parkinson’s disease makes an outcome of maintenance ideal. Participant #4, Daniel, presented 
with greater impairments in vocal functioning from pre-intervention to post-intervention, and his 
data yielded the greatest increase in jitter and shimmer scores. Removing the data points yielded 
the same results, and statistical significance was not achieved.   
 Median scores for maximum phonation time decreased from pre to post-intervention; 
however, the scores were not statistically significant. The statistically significant difference for 
maximum phonation range high was unexpected. The significant difference could be attributed 
to a clearer direction during measurements, or to improved vocal range because of increased 
respiratory strength and more efficient use of the vocal musculature. Increased maximum 
phonation time would indicate that the participants had better control of their respiratory muscles 
and were able to regulate the air flow during testing. A decrease in maximum phonation time 
may be indicative of a loss of control of respiratory musculature. Individual data showed that 
four of the six participants had decreased scores, and two participants had increased phonation 
time. The two participants who had increased times were participant #4, Daniel, and participant 
#6, Josh. The results of these two participants were unexpected. During post-testing, Josh 
experienced a significant dyskinetic even that may have impacted the results of his other acoustic 
measures; however, this measure showed a marked improvement. Daniel had the most 
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significant impairment in vocal functioning and respiratory control. While the same directions 
were given during each testing, the results of the testing may have been influenced by practice 
effect. The music therapy intervention involved extending expiratory time through muscle and 
breath control. Participants were given the opportunity to practice this technique during every 
session. In fact, 4 of the 6 participants experienced decreases in MPT, indicating this practice 
may not have had an effect on the total study population; however, it could have impacted 
individual scores. The results of these two participants is promising; however, in that, they were 
observed has having the most impairment in vocal functioning. Further research by a rater naïve 
to the identities of the study participants of the acoustic measures and a control group would be 
necessary to determine if these changes were clinically significant and due to the intervention. 
While the findings did not reveal statistically significant different, the findings may be clinically 
relevant because participants noted that the techniques learned in intervention helped them to 
regularly practice strengthening their voices. In addition to this, participants regularly shared 
their enjoyment of the intervention, creating a positive experience that participants were more 
likely to regularly attend for extended periods.  
 Median fundamental frequency range in semi-tones remained the same from pre-
intervention to post-intervention; however, the maximum range of the measurement increased 
from 26 semitones to 30 semitones. Mean fundamental frequency range is the measure of the 
fundamental frequency variability available to an individual. As stated previously, people with 
PD present with significantly reduced variability when compared to healthy controls (Bowen et 
al., 2013). While the participants did not experience an improvement in overall scores for mean 
fundamental frequency range, the pitch variability available to them did not decrease across the 
intervention period. It is possible that the intervention helped to maintain pre-intervention level 
Commented [CPL2]: I feel that this information belongs in 
the clinically relevant section. And then here just do a one 
sentence summary of clinical relevance.  
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of functionality in the vocal mechanism. Further research with longer intervention periods and 
testing 3 months post intervention should be employed to determine if this result was indeed 
indicative of maintenance of vocal functionality and if these changes maintain across time.  
 Mean fundamental frequency range low, meaning a patient’s lowest low note, increased 
from pre to post-intervention testing. The mean fundamental frequency range high, meaning a 
patient’s highest high note, also increased post-intervention testing. It is important to discuss 
mean fundamental frequency range as a whole because it is indicative of a patient’s highest and 
lowest notes available. Parkinson’s disease is a degenerative disease that affects dopamine 
production in the basal ganglia. A reduction in dopamine makes use of muscle difficult for the 
individual. Vocal range is created by the coordinated lengthening and shortening of the muscles 
that make up the vocal cords. A person diagnosed with PD may experience a reduction in vocal 
range because of the inability of the vocal cord muscles to properly lengthen and shorten. As 
such, it is common for individuals with PD to have a shortened vocal range, meaning their 
highest high note decreases and their lowest low note increases (Bowen et. al., 2013). In men, it 
is common for the lowest low note to increase substantially. In the current study, the participants 
were found to have a median increase in their lowest low notes, but also an increase in their 
highest high now. While this would indicate that the effects of the disease on the lowest low 
were not improved, it also shows that the intervention may have helped to extend their vocal 
range in their upper register. While these results are interesting, they were not statistically 
significant. Improvement of laryngeal muscular control was expected to equally affect the lower 
and upper registers; however, this was not the case. Further research is needed to determine if 
these effects would be statistically significant with a larger sample size and in comparison with a 
control group.  
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 Fundamental frequency is the place in the voice at which a person is most comfortable. 
This is subjective according to each individual person. The results of this study showed that the 
mean fundamental frequency increased from pre-intervention to post-intervention. This would 
indicate that most comfortable note for the participants became higher across the intervention 
time. The average fundamental frequency for adults in this age range is 141.74 + 21.14. While 
the median of the fundamental frequency increased, this number was still within normal values. 
Half of the participants saw increases in their fundamental frequency; however, these numbers 
were not significant. It is important to note that Participant #4 (Daniel) and Participant #6 (Josh) 
were amongst the three participants who saw decreases in their median fundamental frequency. 
As discussed above, it is possible that the more advanced the impairment, the more improvement 
one will see from the intervention. Further testing with a larger sample size and a control group 
is necessary to determine if these decreases could be generalized to the overall PD population.  
 Mean intensity (dB) scores showed increases from pre to post-intervention testing. The 
act of singing requires greater use of the abdominal muscles to maintain the phonatory intensity 
necessary to maintain phonation (Garcia-López & Gavilàn Bouzas, 2009). The use of singing 
interventions can help to improve vocal intensity through the training of the muscles necessary 
for respiration (Stegemöller et al., 2017). The current study found similar results; however, these 
improvements were not statistically significant. These findings further support the suggestion 
that signing-based interventions can assist in improving vocal intensity through respiratory 
muscle strengthening. Further testing is necessary to further support use of singing based 
interventions for respiratory strength in people diagnosed with PD.  
While some of the results were promising, the lack of statistical significance was 
expected based on the small sample size and relative intensity of the intervention. Furthermore, 
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some of the results were more promising for the patients with greater observed impairment than 
those who maintained relatively normal functionality in their vocal mechanisms. This may 
suggest that results may be more significant for those with greater impairment; however, earlier 
applicability of the intervention exercises may help to maintain vocal functionality as the disease 
progresses.  
Specific Aim 2: To examine the effect of NMT voice protocol on perception of voice quality 
following 8-week intervention period as measured by CAPE-V.  
 The results from this study suggest that a music therapy protocol using NMT techniques 
may be effective in maintaining or improving vocal functioning according to the CAPE-V. The 
CAPE-V ratings yielded the most statistically significant results of the research study. According 
to the scores by the rater naïve to the identities of the study participants, there were statistically 
significant decreases in breathiness, pitch, loudness, and overall severity of voice. The 
intervention of the present study had exercises focused on improving pitch and breath control. 
Increased awareness of the respiratory system and control over the respiratory muscle could have 
contributed to these improved ratings. When clients were tested pre-intervention, the majority 
had no previous knowledge of singing and breath control. Singing requires use and control of 
both the respiratory and phonatory muscles (Garcia-López & Gavilàn Bouzas, 2009). Prolonged 
use and practice using these muscles can help to improve the overall efficiency of the vocal 
mechanism. As shown by Garcia-López and Gavilàn Bouzas (2009), singing requires greater 
muscular coordination than speaking. Changes in tone require control of the abdominal and 
phonatory muscles. As the participants practiced these techniques in session, their control over 
this musculature could have improved. This improvement in efficiency and coordination of the 
phonatory and respiratory muscles could have impacted the rater’s perception of their vocal 
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function. Further research is needed with a larger sample size to determine if the statistical 
significance can be generalized to the greater PD population. Research with a control group is 
also necessary to determine if the results were similar with healthy adults as with those 
diagnosed with PD. Further research is also needed to compare a matched control group of 
individuals with PD who do not participate in a singing-based intervention to those who do 
receive singing interventions. 
Three participants had increased (worsening) scores for strain from pre-intervention to 
post-intervention measures. While these results were unexpected, the increased scores could 
have been contributed to response bias as the participants strained their voices to make their 
voices sound different or more improved. The lead researcher also administered the final 
measurements, which may have impacted the way the participants responded to the directions 
given. Additional research with both a rater naïve to the identities of the study participants, and a  
researcher naïve to the identities of the study participants may help to remove any bias associated 
with the results.  
Specific Aim 3: To examine the effect of NMT voice protocol on voice-related quality of life 
as measured by VR-QOL and VHI.  
 There were no statistically significant differences for the Vocal Handicap Index (VHI) or 
the Voice-Related Quality (V-RQOL) of Life self-report measures. The ability to communicate 
positively impacts a person’s quality of life and their ability to build positive social interactions 
(Takahashi, et al., 2016). When communication is impaired from a degenerative disease, such as 
PD, that impairment can negatively affect a person’s perceived quality of life (McAuliffe et al., 
2017).   
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 All of the subscale scores for the V-RQOL were decreased during post-intervention. This 
would indicate that the participants perceived their vocal impairment as having less of an impact 
on their quality of life. These scores, however, were not statistically significant. The differences 
in change between the VHI and the V-RQOL may be attributed to the sensitivity of the measures 
to report vocal impairment and its effect on quality of life. The V-RQOL is a 10-item 
questionnaire, whereas, the VHI is a 30-item questionnaire. The results of the current study 
support the findings that the VHI may be more sensitive to the unique experiences of the PD 
population and the impact of voice impairment on quality of life. Further research is needed with 
to determine the effectiveness and sensitivity of each self-report measures of vocal impairment 
on quality of life within the PD population. See Table 8 for a concise presentation of variables, 
hypotheses, and findings.  
Table 8 
 
Variables, Hypotheses, and Findings 
Variables Hypothesis Findings 
Jitter (%) Decrease  
Shimmer (%) Decrease  
Fftr (Hz) Decrease  
MPT (sec.) Increase  
MPR Lowest Note (Hz) Lower  
MPR Highest Note (Hz) Higher  
Mean F0 (HZ) Decrease  
Mean F0 Range (Semitones) Increase – 
Mean Intensity (dB) Increase  
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Table 8 (continued.)
  - improvement  - worsening – - maintaining
 
Implications for Music Therapy Practice 
 Tamplin et al. (2019) have begun investigating into singing-based therapy on vocal, 
intensity, maximum phonation time, expiratory and inspiratory pressure, and voice-related 
quality of life in people with PD over a period of a year, but this is the first study of its kind in 
the United States utilizing a control group and longer term treatment period. Current research 
acknowledges that voice changes occur frequently with PD; however, a treatment strategy using 
a music therapy protocol using NMT techniques has not been standardized to best benefit this 
population. This type of research is necessary to further solidify music therapy as a viable 
treatment option for voice changes in people with PD. Further research by board certified music 
therapists needs to be conducted with the PD population to focus on voice and voice changes 
associated with the disease. Music therapy research with PD needs to focus on developing a 
systematized treatment strategy for voice in collaboration with speech-language pathology.  
Limitations 
 While this research did not yield results revealing many variables with statistically 
significant differences pre-intervention to post-intervention, it is important to acknowledge the 
limitations and possible biases that may have impacted the results. Design bias was inherent as 
there were only six participants in the study who were recruited from a convenience sample of a 
s/z Ratio Less than 1:4  
CAPE-V Decrease  
VHI Decrease  
V-RQOL Decrease  
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Parkinson’s support group familiar to the researcher. While none of the participants had received 
music therapy previously, they were familiar with the treatment method from previous 
presentations within the group. This may have introduced an inclusion bias into the research. In 
addition to this limitation, there was not a control group with which to compare the results.  
 Further limitations were present in procedural bias during testing. The subjects were 
asked to complete questionnaires within a short time frame and may have adjusted their answers 
to best fit the aims of the present study. Measurement bias may have also occurred from the 
principal researcher also taking final measurements and therefore could not be blinded during 
this assessment. The participants and the researcher built a therapeutic relationship during the 
course of the study, and the participants may have adjusted their performance during testing to 
best fit the aims of the study leading to a response bias.  
Recommendations for Future Research 
While this research did not yield results revealing many variables with statistically 
significant differences pre-intervention to post-intervention, the results further support that 
singing-based interventions may be beneficial in improving vocal functionality in people 
diagnosed with PD. At this time, there has only been one study that has researched the effects of 
NMT interventions on voice in with a larger population of people diagnosed with PD while also 
including a control group. There needs to be further research with increased experimental group 
size and healthy controls. Furthermore, additional measures need to be taken post-intervention to 
determine if the effects of the treatment will remain long term. Additionally, future studies must 
include measurements from speech language pathology and encourage the collaboration between 
these two disciplines. LSVT has proven to be a powerful tool for the improvement of vocal 
functioning in people with PD, but the intensity of the treatment may make it inaccessible to 
 
 67 
some patients. The treatment requires multiple weekly sessions with added at-home exercises 
nightly. This treatment strategy may require too much time for participants to commit fully. A 
combined treatment option that encourages social interaction and vocal improvement through 
singing interventions may provide a unique opportunity for beneficial change. Collaborative 
research with large sample sizes, control groups, and trained raters naïve to the identities of the 
study participants is necessary to find the most benefit for the patients.  
Summary and Conclusion 
 This study examined the impact a music therapy protocol using NMT techniques on 
speaking voice and quality of life in individuals with PD based on acoustic, perceptual, and self-
report measures taken before and after treatment. While some positive changes were apparent 
from the current study, the researcher found no statistical significance for the acoustic and self-
report measures. While the findings did not reveal statistically significant different, the findings 
may be clinically relevant because participants noted that the techniques learned in intervention 
helped them to regularly practice strengthening their voices. Clinically, this finding is relevant 
because increases the likelihood of the participants future implementation of the techniques in 
their daily lives.  Perceptual measures through the use of the CAPE-V and a qualified rater naïve 
to the identities of the study participants yielded statistically significant improvement in 
breathiness, pitch, loudness, and overall severity. Singing interventions utilize training and 
coordination of phonatory and respiratory muscles. Thus, improvements in the perceptual 
measures are promising in showing that singing-based interventions may positively impact vocal 
functioning in people diagnosed with PD.  
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Appendix A: Consent to Participate in Research 
Information to Consider About this Research 
  
Study Title: Neurologic Music Therapy to Improve Speaking Voice in Individuals with 
Parkinson's Disease  
IRB Number: 19-0215 
Principal Investigator: Sarah Swann Solberg, MT-BC  
Department: Hayes School of Music 
Contact Information:   
swannsl@appstate.edu, (828) 231-2562 
 
Faculty Advisor: Dr. Christine Pollard Leist, MT-BC  
Department: Hayes School of Music 
Contact Information:   
leistcp@appstate.edu, (828) 262-6663 
 
What is the purpose of this research?  
 
You are being invited to take part in a research study investigating the effects of neurologic 
music therapy techniques on speaking voice in people diagnosed with Parkinson’s disease. If you 
take part in this study, you will be one of about 5 people to do so.  By completing this study, we 
hope to: 1) demonstrate music therapy as an effective treatment for voice disorders from 
Parkinson’s disease, 2) explore a standardized treatment method using effective music therapy 
interventions, and 3) improve the speaking voices of individuals experiencing voice changes 
from Parkinson’s disease.  
 
This study will be conducted by a board-certified music therapist with further certification in 
neurologic music therapy techniques specifically designed to work with voice disorders.    
 
You will be asked to take part in weekly one-hour music therapy sessions for 8-weeks, as well as 
to continue practicing the techniques at home. You will also be asked to undergo acoustic 
measurements of your vocal functioning. Total time commitment will be 9-weeks for one hour 
per week.  
  
What possible harms or discomforts might I experience during the research? 
  
To the best of our knowledge, the risk of harm for participating in this research study is no more 
than you would experience in everyday life.  
  
What are the possible benefits of this research? 
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There may be no personal benefit from your participation in this study. Determining the 
effectiveness of this treatment will help to inform future research for working with individuals 
diagnosed with Parkinson’s disease.  
 
Will I be paid for taking part in the research? 
  
You will not be paid for completing this study, and there is no cost to you for the music therapy 
session. 
  
How will you keep my private information confidential? 
  
Personal information will only be shared with the principal investigator. All participants will be 
assigned a random identification number and any documentation will be coded with this number 
to ensure anonymity. No other members of the research team will have access to any identifying 
data. Once the study is completed, aggregate data from the study will be analyzed using this 
unique identification number. All personalized information will be stored on a password 
protected encrypted device. All data will be destroyed after one year. 
 
Who can I contact if I have questions? 
  
The people conducting this study will be available to answer any questions concerning this 
research, now or in the future.  You may contact the Principal Investigator, Sarah Swann 
Solberg, at (828) 231-2562 or through email at swannsl@appstate.edu.  If you have questions 
about your rights as someone taking part in research, contact the Appalachian Institutional 
Review Board Administrator at (828) 262-2692 or through email at irb@appstate.edu or at 
Appalachian State University, Office of Research and Sponsored Programs, IRB Administrator, 
Boone, NC 28608. 
 
Inclusion Criteria 
 
1. Diagnosed with Stage 2 or 3 PD based on the Hoehn and Yahr scale (Hoehn & Yahr, 
1967) 
2. No previous music therapy services to address speaking voice 
3. Willing to sing to participate in a vocal protocol utilizing NMT techniques 
4. English as first language 
5. Age range: 45-80 
6. No reported co-morbidity of a respiratory disorder/disease 
7. Can follow 2-3 step commands without repetition 
8. Not currently receiving speech-language pathology services 
 
 
Exclusion Criteria 
 
1. Diagnosed with stage 1 or 4 PD based on the Hoehn and Yahr scale 
2. Currently receiving speech-language pathology or music therapy to address voice 
disorders 
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Do I have to participate?  What else should I know? 
  
Your participation in this research is completely voluntary.  If you choose not to volunteer, there 
will be no penalty and you will not lose any benefits or rights you would normally have. If you 
decide to take part in the study, you still have the right to decide at any time that you no longer 
want to continue. There will be no penalty and no loss of benefits or rights if you decide at any 
time to stop participating in the study. If you decide not to participate in this study, let the 
research personnel know. You may request a copy of this consent information by contacting the 
Principal Investigator, Sarah Swann Solberg, at (828) 231-2562 or through email at 
swannsl@appstate.edu. 
  
This research project has been approved by the Institutional Review Board (IRB) at Appalachian 
State University. 
 
This study was approved on 2/14/2019. 
 
This approval will expire on 2/14/2020 unless the IRB renews the approval of this research. 
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Consent to Participate in Research 
Information to Consider About this Research 
 
I agree to participate as a participant in this research project, which concerns music therapy 
techniques to improve speaking voice in people diagnosed with Parkinson’s disease.  The 
measurements(s) will take place at the Communication Disorders Clinic at Leon Levine Hall on 
Appalachian State Campus. Measurements will be taken once prior to treatment and once 
posttreatment. Each measurement session will last approximately 45 minutes. Treatment will 
take place in a private room once per week at University Hall at Appalachian State University. 
Treatment will be for 8-weeks and each treatment session will be approximately 60 minutes. I 
understand the treatment will be about voice rehabilitation. 
 
I understand that there are no foreseeable risks associated with my participation.  I also know 
that this study may improve my speaking voice and help to inform future treatment options for 
people experiencing voice disorders from a diagnosis of Parkinson’s disease. 
 
I understand that the measurement(s) will be audio recorded and may be published.  I understand 
that the audio recordings of my measurement session may be stored on an encrypted, password 
protected computer and may be used for presentations or published data if I sign the 
authorization below.   
 
I give Sarah Swann Solberg, MT-BC ownership of the tapes, transcripts, recordings and/or 
photographs from the measurement(s) and treatment(s) she conducts with me and understand that 
tapes and transcripts will be kept in the researcher’s possession. I understand that de-identified 
information or quotations from audio recordings or transcripts will be published. I understand I 
will not receive compensation for participation in the study.  
 
I understand that the participation is voluntary and there are no consequences if I choose not to 
participate.  I also understand that I do not have to answer any questions and can end the 
treatment at any time with no consequences.   
 
If I have questions about this research project, I can call the researcher at (828) 231-2562 or the 
Appalachian Institutional Review Board Administrator at 828-262-2692(days), through email at 
irb@appstate.edu or at Appalachian State University, Office of Research Protections, IRB 
Administrator, Boone, NC 28608. 
 
This research project has been approved on _____(date) by the Institutional Review Board (IRB) 
at Appalachian State University.  This approval will expire on [Expiration Date] unless the IRB 
renews the approval of this research. 
 
I request that my name not be used in connection with tapes, transcripts, photographs or 
publications resulting from this interview.  
 
I request that my name be used in connection with tapes, transcripts, photographs or 
publications resulting from this interview. 
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By signing this form, I acknowledge that I have read this form, had the opportunity to ask 
questions about the research and received satisfactory answers, and want to participate.  I 
understand I can keep a copy for my records.  
 
 
 
     _______        
Participant's Name (PRINT)                                 Signature                           Date  
 
 
 
Photography and Video Recording Authorization 
 
With your permission, still pictures (photos) and/or video recordings taken during the study may 
be used in research presentations of the research findings.  Please indicate whether or not you 
agree to having photos or videos used in research presentations by reviewing the authorization 
below and signing if you agree.   
 
Authorization 
I hereby release, discharge and agree to save harmless Appalachian State University, its 
successors, assigns, officers, employees or agents, any person(s) or corporation(s) for whom it 
might be acting, and any firm publishing and/or distributing any photograph or video footage 
produced as part of this research,  in whole or in part, as a finished product, from and against any 
liability as a result of any distortion, blurring, alteration, visual or auditory illusion, or use in 
composite form, either intentionally or otherwise, that may occur or be produced in the 
recording, processing, reproduction, publication or distribution of any photograph, videotape, or 
interview, even should the same subject me to ridicule, scandal, reproach, scorn or indignity. I 
hereby agree that the photographs and video footage may be used under the conditions stated 
herein without blurring my identifying characteristics.  
 
 
             
Participant's Name (PRINT)                                 Signature                           Date  
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Vita 
 Sarah Swann Solberg was born in Crossnore, North Carolina, but grew up in Asheville, 
North Carolina, as the youngest of five children. She was on the Dean’s List for Academic 
Excellence for the duration of her undergraduate career and graduated cum laude from 
Gettysburg College in Gettysburg, Pennsylvania.  She earned a Bachelor of Music degree in 
vocal performance in May 2011. In December 2013, she began her Master of Music in vocal 
performance at Appalachian State University and graduated in December 2015. She began the 
combined Equivalency and Master of Music Therapy program at Appalachian State University in 
the summer of 2015. She was awarded a Provost Fellowship for the Spring of 2018, and she was 
a recipient of the Gary “GJ” Leadership and the F.H. “Sammy” Ross, Jr. Memorial Scholarships. 
She is also a member of the Pi Kappa Lambda Music Honors Society. Mrs. Solberg completed 
her music therapy internship at Park Nicollet Health Services in January 2018. She earned her 
music therapy board certification in January of 2018. 
 Mrs. Solberg currently works as a hospice music therapist for Medi Home Health and 
Hospice in Boone, North Carolina, and works for Medi Home Health and Hospice as a hospice 
music therapist. She currently resides with her loving husband, two amazing dogs, and one sweet 
bunny in Vilas, North Carolina.  
